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These studies have investigated the effects o f  some novel synthetic derivatives o f 
palm itoyl carnitine in the isolated, perfused rat heart, isolated rat left atrium  and 
isolated rat ventricular m yocyte preparation.
In structure-activity  relationship studies, it was found that the absence o f a negatively 
charged group from  palm itoyl carnitine, ie. the carboxylic acid group, produces 
com pounds which are potent coronary dilators in the isolated perfused rat heart. It 
was also found that the positively charged quaternary nitrogen group was a necessary 
requirem ent for vasodilator activity.
F urther studies w ere concerned with investigating the m echanism  o f  action o f one such 
coronary dilator derivative o f palm itoyl carnitine, nam ely the isopropyl ester o f 
palm itoyl carnitine (P IP i) , in the isolated perfused rat heart. It was found that this 
derivative was able to inhibit the coronary constrictor response to BAY K 8644, but 
not to caffeine or a low sodium  perfusate. A dditionally , P IP i was able to inhibit the 
positive inotropic response to noradrenaline, prostaglandin F 2a  and m ethoxam ine, but 
not in response to a low sodium  perfusate. The positive chronotropic response to 
noradrenaline was also unaffected.
In the isolated left atrium  o f the rat, P IP i had no effect on noradrenaline-induced 
positive inotropic responses. H ow ever, in isolated rat ventricular m yocytes, P IP i was 
able to inhibit the noradrenaline-induced increase in the am plitude o f  calcium 
transients produced in response to electrical stim ulation, m easured with the fluorescent 
calcium  probe fura-2 .
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In conclusion, P IP i appears to be able to m odulate both calcium  entry through L-type 
calcium  channels in smooth muscle and processes involving agonist-induced 
phosphorylation within the m yocardium , but does not affect calcium  release from  the 
sarcoplasm ic reticulum , sodium -calcium  exchange or the pacem aker current If. It is 
proposed that these effects o f P IP i are m ediated via an alteration o f charge on the 
sarcolem m al surface o f the cell.
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In tro d u c tio n
1. Role of acyl ca rn itin es  in fatty acid m etabolism .
Acyl carnitines are compounds formed during the process of fatty acid metabolism 
within cells. In cardiac muscle, the main source o f energy is from fatty acids which 
are transported across mitochondrial membranes for subsequent B oxidation via the 
carrier molecule carnitine, which combines with fatty acids to form acyl carnitines 
(Fritz, 1963; Brem er, 1983). The scheme for this metabolic pathway is outlined 
below (Figure 1):- 
F igure 1
The role o f palm itoyl carnitine in fatty acid metabolism within the cell.
FREE FATTY ACIDS
C ytosol
In m em brane:
Fatty acyl coA  syn thetase |  O u te r m itochondria l m em brane
C arn itine  acyl tran sfe rase  I
A<__________ _____ _
A CY L CoA
/ r  C A R N IT IN E In ter m em brane space
In m em brane: 
T ran s lo ca se (B arrie r to passage o f  acyl coA )
Inner m itochondria l m em brane
ACY L CA R N ITIN E M itochondria l m atrix
C arn itin e  acy l transferase  II C oA
C A R N IT IN E
Y
A CY L CoA
Y
fi-oxidation
A C E T Y L  CoA N A D H  +  F A D H 2 >  A T P
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2. Effects of acyl carnitines in the heart following accumulation under conditions 
of ischaemia.
U nder normal conditions carnitine is recycled following the dissociation o f fatty acyl 
groups, catalysed by carnitine acyl transferase II (Fritz, 1963; W oeltje et a l . , 1990) 
and fatty acids are released within the m itochondrial m atrix for subsequent ft 
oxidation. H ow ever, in the ischaemic m yocardium  there is insufficient oxygen 
present for ft oxidation o f fatty acids and therefore there is a build up o f both acyl 
CoA and acyl carnitine (Liedtke et a l., 1978, Idell-W enger et a l., 1978; Katz & 
M essineo, 1981). Long chain acyl carnitines, a m ajor constituent o f which is 
palm itoyl carnitine, have been reported to increase 3.5 fold within 2 minutes of 
ischaem ia in vivo (D atorre et a l., 1991) and there is evidence to suggest that there is 
a preferential partitioning into the sarcolem m a by way o f their fatty acid chains (Fink 
& G ross, 1984; M eszaros, 1991). For exam ple, W u et al. (1993) m easured a 100 
fold increase in acyl carnitines in the junctional sarcolem m a o f isolated myocytes 
subjected to 10 minutes hypoxia, and Knabb et al. (1986) m easured more than a 70 
fold increase in the sarcolem m a. This is likely to contribute to the m em brane 
dysfunction and electrophysiological disturbances produced following ischaemia 
(Corr et a l., 1984; Knabb et a l., 1986). Heathers et al. (1987) reported an increase 
in a \-ad ren o cep to rs  in canine myocytes subject to hypoxia, correlating with an 
increase in endogenous long chain acyl carnitines. This has also been shown to occur 
under ischaemic conditions in vivo (A llely & Brown, 1988), and may contribute to 
the arrhythm ogenic effect o f acyl carnitines, as in separate studies a-adrenoceptor 
stim ulation.has been shown to be arrhythm ogenic (Culling et a l., 1987).
A ccum ulation o f long chain acyl carnitines in the sarcolem m a has been reported to 
produce cell-cell uncoupling due to a decrease in the gap junctional conductance 
(Knabb et a l., 1986; Yamada et a l., 1994; W u et a l., 1993), which has also been 
show n to contribute to the developm ent o f arrhythm ias through re-entry pathways 
(Janse & W it, 1989). Acyl carnitines have also been show n to produce an increase in
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intracellular calcium  within myocytes (Wu & C orr, 1992), which may be responsible 
for the calcium  overload produced following ischaemia. The mechanism for the 
calcium  increase has not yet been established. Spedding & Mir (1987) and Patmore 
et al. (1989) suggested that palmitoyl carnitine produced during ischaemia may act as 
an endogenous voltage gated calcium  channel activator resem bling BAY K 8644. 
H ow ever W u & C orr (1992), directly m easuring calcium  currents in isolated 
m yocytes found palm itoyl carnitine to actually inhibit the voltage dependent calcium 
current. They also found that palm itoyl carnitine delayed the inactivation o f sodium 
inward curren t (W u & Corr, 1994), and suggested that the increase in intracellular 
calcium  produced in response to palm itoyl carnitine was a secondary effect due to an 
increase in Ca^ +  influx via N a+ -Ca2 +  exchange following a rise in intracellular 
N a + , and subsequent calcium -induced calcium  release from  the sarcoplasm ic 
reticulum . Palm itoyl carnitine has also been shown to directly activate the calcium 
release channel (ryanodine receptor) o f the sarcoplasm ic reticulum  (El-H ayek et a l.,
1993), and if this effect occurs in m yocytes, this may also contribute to the rise in 
intracellular calcium  produced by palm itoyl carnitine. A direct inhibitory effect on 
N a +  dependent Ca^ +  uptake via electrogenic N a ^ -C a ^ T  exchange (Philipson & 
N ishim oto, 1982; Lam ers et a l., 1984) has also been reported for palm itoyl carnitine, 
which contradicts the mechanism o f calcium  increase proposed by Wu & Corr (1992;
1994) for palm itoyl carnitine, see above. H ow ever, far higher concentrations of 
palm itoyl carnitine were required for inhibition o f Na +  -C a2 +  exchange (up to 
100/zM for com plete inhibition o f the exchange process (Lamers et a l., 1984)), than 
were used in W u & C o rr 's  studies (5-10/xM). Palm itoyl carnitine has also been 
dem onstrated to have an biphasic effect on protein kinase C activity, stim ulatory at 
low concentrations and inhibitory at higher concentrations (Wise et a l., 1982). 
Reports o f  the effects o f palm itoyl carnitine on potassium  currents and action 
potential duration have been equivocal. Som e studies have shown an increase in 
action potential duration in response to low er concentrations o f palm itoyl carnitine 
(M eszaros &  Pappano, 1990), which may be related to the increase in m em brane 
stabilisation and hence decrease in potassium  perm eability (M eszaros, 1991).
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C onversely, others have shown a shortening o f the action potential duration in 
response to palm itoyl carnitine (C orr, 1981; Wu & Corr, 1992), which may 
contribute to the arrhythm ogenic action which occurs as a consequence o f a reduction 
in action potential duration under ischaemic conditions. These discrepancies may be 
due to the fact that the effect on action potential duration appears to be dependent on 
the concentration o f palm itoyl carnitine used, as at higher concentrations, M eszaros 
& Pappano (1990) also showed a decrease in action potential duration; additionally 
the effects o f palm itoyl carnitine on other ion currents eg. current through L-type 
calcium  channels must be taken into account in the effect on action potential, and the 
decrease in calcium  current may contribute to the decrease in action potential 
duration show n by W u & C orr (1992). Palmitoyl carnitine has also been shown to 
depolarise the resting m em brane potential (Corr et a l., 1984: M eszaros & Pappano, 
1990), which may be explained by the inhibition o f sodium current inactivation (Wu 
& C orr 1992; 1994), although m odulation o f the inward rectifier potassium channel 
current has also been proposed for this effect (Sato et a l., 1993). The depolarisation 
o f resting m em brane potential by palm itoyl carnitine may also contribute to increased 
autom aticity and the developm ent o f  arrhythm ias.
The actions o f palm itoyl carnitine at concentrations up to l^M  may be related to 
their ability to stabilise cell m em branes (M eszaros, 1991; Epand & Lester, 1990).
At higher concentrations, > 3 0 juM , palm itoyl carnitine has been shown to produce 
m yocyte disruption (M eszaros Sc Pappano, 1990), through its am phiphilic detergent 
action (C orr et a l., 1984) and this may account for the m ultiple effects on m em brane 
bound enzym es at higher concentrations for exam ple, inhibition o f N a“*"-K +  -ATPase 
(Adams et a l., 1979), inhibition o f C a^T -A T P ase  in the sarcoplasm ic reticulum 
(Pitts et a l., 1978).
The structure o f palm itoyl carnitine is show n in Figure 2 (see below). Like all long 
chain acyl carnitines, palm itoyl carnitine is an am phiphilic zwitterion containing
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lipophobic positively (quaternary nitrogen) and negatively (carboxylic acid) charged 
groups, as well as a lipophilic fatty acid chain (palm itoyl).
3. Effects o f palmitoyl carnitine on smooth muscle.
Few er studies have been carried out to investigate the effects o f acyl carnitines in 
sm ooth m uscle. How ever, Corr et al. (1984) reported that palm itoyl carnitine is able 
to leak into the extracellular space during prolonged ischaem ia, and therefore any 
vascular effects o f acyl carnitines may be o f relevance to ischaem ic injury. Spedding 
and M ir (1987) found that in potassium  depolarised sm ooth m uscle o f guinea pig 
taenia coli, palm itoyl carnitine produced a contraction resem bling the L-type calcium 
channel agonist BAY K 8644, and the sam e effect has been described in contracting 
depolarised rat aorta (Dainty et a l., 1990). Palm itoyl carnitine has also been reported 
to inhibit both basal and receptor m ediated release o f  ED R F from the endothelium  
(D ainty et a l., 1990; Inoue et a l., 1994).
4. Effects o f exogenous palmitoyl carnitine in the isolated perfused rat heart.
In term s o f coronary vascular effects, C riddle et al. (1987; 1990) dem onstrated that 
palm itoyl carnitine can produce a coronary constrictor effect in the isolated perfused 
rat heart, together with an irreversible depressor action on cardiac contractility and no 
effect on heart rate. W hilst investigating the vascular effects o f palm itoyl carnitine in 
the isolated w hole heart, C riddle et al. (1987; 1988) observed an anom alous response, 
nam ely a coronary dilation, produced in response to palm itoyl carnitine in some 
preparations. Further investigation led to the discovery that palm itoyl carnitine had 
becom e contam inated with the ethyl ester derivative, form ed from the ethanol 
contained w ithin the storage medium (C riddle et a l., 1990). The reaction is outlined 
below  (F igure  2).
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Figure 2
Reaction for the esterification o f palm itoyl carnitine.
Palmitoyl carnitine
PA LM
* Ethanol (5% in chloroform)
x ofH h o ; c h 2c h 3
v
H - 0
Ethyl ester of palmitoyl carnitine (PIE)
CH
P A L M
\
0 -C H 2CH3
5. Actions of novel ester derivatives of palmitoyl carnitine in isolated perfused rat 
heart.
Upon purification, this ethyl ester derivative, as well as other ester derivatives of 
palm itoyl carnitine, were found to be pure dilators in the isolated perfused rat heart.
At the doses used, no effect on either basal contractility or basal heart rate was 
produced. It can be seen from the above figure that the esterification o f palmitoyl 
carnitine converts the m olecule from  a zw itterion with an overall neutral charge to a 
m olecule with a single positive charge. Initial structure-activity relationship studies 
show ed that the dilator activity o f  these novel acyl carnitine derivatives is highly 
dependent on the length o f the fatty acid (acyl) chain (Criddle et a l., 1991). W hen 
acyl chain length vs. coronary dilator potency for the ethyl ester derivatives o f acyl 
carnitines was plotted, a bell shaped curve was obtained, with a 16 carbon fatty acid 
chain length, palm itoyl, producing the greatest coronary dilator potency. Altering the 
ester grouping at the C term inus o f  the carnitine moiety had a less profound effect on
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dilator activity (Criddle et a l., 1990). However, the isopropyl ester of palmitoyl 
carnitine (PIP i) was found to be marginally more potent than the ethyl ester first 
discovered. Therefore, PIP i was selected as the reference dilator compound and used 
in subsequent experiments investigating the mechanism o f action o f such compounds.
6. A ction o f the  isopropyl ester of palm itoyl ca rn itin e  in o th e r tissues.
Further studies investigating the action o f P IP i have shown it to be a potent 
vasodilator in other perfused vascular beds including the mesenteric vascular bed, the 
perfused rat tail vascular bed (via caudal artery) and the isolated perfused rat kidney 
(Figure 3).
F igure  3
Actions o f P IP i in isolated vascular preparations from the rat; the isolated, perfused 
rat heart (a), mesenteric vascular bed (b), isolated perfused kidney (c) and perfused rat 
tail (d).
a. In the isolated, perfused rat heart, com pared with the actions of amyl nitrate (AN), verapamil 
(VER), iloprost (ILO), ethyl ester o f palm itoyl carnitine (P IE ) and cromakalim (Crk). Effects 
on developed tension (DT), heart rate (HR) and perfusion pressure (PP).
500 5 m in s
( b e a t s  min
m m H g )
Crk Ilo P1E
1
20 1 0.3 Drug (nmol
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Figure 3 cont.
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In contrast to the effects in perfused vascular preparations, containing an intact 
m icrovasculature, P IP i was found to be inactive in isolated sm ooth muscles and 
conduit vessels such as the guinea pig taenia coli and the rat hepatic portal vein or 
preconstricted rat aorta (Criddle et a l., 1992).
7. M echanism of action of the isopropyl ester o f palmitoyl carnitine (PIPi).
Studies investigating the m echanism  o f  action o f  P IP i have m ainly been carried out 
using the isolated perfused rat heart and the m esenteric vascular bed o f the rat. These 
studies have concluded that the vasodilator action o f P IP i is via a direct action on the 
sm ooth m uscle rather than via the release o f  ED R F (NO), or E D H F, from endothelial 
cells (C riddle et al. 1994), as in air dam aged m esenteric vascular beds, the 
vasodilator effect o f P IP i was not attenuated. In addition, in whole hearts vasodilator 
responses w ere not attenuated by L-N G-nitroarginine, or enhanced by superoxide 
dism utase, also indicating a lack o f involvem ent o f  ED RF (NO). Criddle et al.
(1994) also concluded that the vasodilator action o f  P IP i does not appear to be 
m ediated via the release o f arachidonic acid m etabolites as the cyclo-oxygenase 
inhibitor flurbiprofen and the dual cyclo-oxygenase / 5-lipoxygenase inhibitor 
BW 755C had no effect on the vasodilator response. The action is not mediated via 
activation o f bradykinin B2 receptors as the selective antagonist D -A R G ^[H Y P^- 
T H I ^ - D - P H E ^ b r a d y k i n i n  not attenuate the response. Finally, there appears to 
be no involvem ent o f A T P  dependent K +  channels in the dilator action o f P IP i, as 
responses w ere unaffected by the ATP dependent K~*~ channel blocker glibenclam ide. 
The fact that P IP i also inhibited calcium -induced constrictions in the llO m M  K +  
depolarised m esenteric vascular bed (C riddle et a l., 1992; 1994) also implies lack o f 
involvem ent o f o ther types o f K +  channel. H ow ever, unpublished observations 
showed that the addition o f negatively charged dextran to the perfusion medium o f 
isolated rat hearts was found to attenuate the P I Pi-induced coronary  dilator action, 
indicating that the positive charge on the m olecule is likely to be im portant in eliciting
a vasodilator response. This could explain the d ifferent effects o f P IP i, com pared 
with those o f  the parent com pound palm itoyl carnitine, which is a zw itterion and 
therefore overall neutral molecule. It would also indicate a site o f action on the outer 
sarcolem m al surface, possibly affecting ion channel function, as charged com pounds 
cannot cross sarcolem mal membranes due to the hydrophobic core o f  the lipid bilayer 
(Katz, 1992). O ther positively charged am phiphiles, for exam ple polym yxin B (Burt 
et a l., 1983) and dodecyltrim ethylam m onium  (D D TM A ) (Post et a l . , 1991), have 
been show n to decrease the calcium  current through L-type calcium  channels in 
m yocardial cells, while negatively charged am phiphiles, for exam ple dodecylsulphate 
(D D S), increase it (Post et a l., 1991). The ability o f positively charged am phiphiles 
to decrease calcium  current is probably due a decrease in the anionic surface charge on 
the external sarcolem m al surface, produced by binding o f  the cationic am phiphile, 
which increases the potential difference across the sarcolem m a, thus im pairing the 
excitability  o f  the voltage gated calcium  channel (G reen & Andersen, 1991; Latorre et 
a l., 1992). A lthough P IP i had no effect on basal cardiac contractility , this may 
explain the action o f the positively charged am phiphile on vascular smooth m uscle.
As C riddle et al. (1992; 1994) also showed that in the m esenteric vascular bed, P IP i 
is able to attenuate the constrictor action o f calcium  ions in potassium  depolarised 
preparations, this indicates that P IP i is able to inhibit voltage gated calcium  channels 
in sm ooth muscle.
Interestingly, the parent molecule palm itoyl carnitine has itself been shown to reduce 
surface negative charge within the m yocardium  (Inoue & Pappano, 1983; M eszaros et 
a l., 1988; M eszaros, 1991), which would indicate an inhibitory effect o f palm itoyl 
carnitine, as well as the ester derivatives, on the L-type calcium  channel, as well as 
other excitatory ion currents eg. sodium  curren ts, and several studies (Inoue & 
Pappano, 1983; W u & Corr, 1992; Sato et a l., 1992) have shown that this is indeed 
the case, at least in myocytes. Other m echanism s are therefore likely to be responsible 
for the vasoconstrictor action o f palm itoyl carnitine in coronary sm ooth muscle eg. via
N a + -C a ^ +  exchange, secondary to an increase in intracellular sodium or calcium  
release from  the sarcoplasm ic reticulum  (See above).
8. Aims of the present study.
The initial studies described in this report w ere carried out in the isolated perfused rat 
heart, to investigate the effects o f the novel acyl carnitine derivatives on the coronary 
vasculature (F igure 4). Firstly , to perform  further structure-activity relationship 
studies on novel acyl carnitine derivatives, in order to pin-point the features o f the 
m olecule w hich confer vasodilator activity. By studying com pounds containing 
d ifferen t groupings in place o f  the isopropyl ester group at the C term inus o f the 
m olecule, it was possible to investigate w hether an ester group is im portant in 
conferring coronary  dilator activity. By keeping the C term inus constant and changing 
the groups attached to the quaternary nitrogen at the N term inus o f the m olecule, the 
im portance o f  charge on activity was investigated. In addition, these studies further 
investigate the m echanism s o f action o f  these novel vasodilator acyl carnitine 
derivatives, in particular P IP i, in the isolated perfused rat heart preparation. This 
preparation allow s the study o f the action o f  agents on the coronary vasculature and 
the cardiac m uscle sim ultaneously, by perfusion o f  the coronary vessels via retrograde 
perfusion o f  the aorta  (Figure 4).
Figure 4
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During the course o f these experim ents an additional property o f PI Pi was discovered, 
nam ely the ability  to suppress agonist-induced increases in coronary contractility whilst 
having no significant effect on basal contractility in isolated perfused heart 
preparations. Studies were therefore carried out using isolated atria and isolated 
m yocyte preparations as well as whole hearts, in order to elucidate the m echanism s 
involved in this additional property o f P I Pi. In order to investigate the m echanism  of 
action o f  P IP i in the coronary vasculature and the m yocardium , the effect o f P IP i on 
responses to BAY K 8644, noradrenaline, m ethoxam ine, prostaglandin F2 a  (PG F2 a ), 
caffeine and a low sodium  perfusate were investigated, which are able to increase 
m yocardial contractility  and produce smooth muscle contraction in different ways, 
outlined below .
8.1 M echanisms o f smooth muscle contraction.
In vascular sm ooth muscle, BAY K 8644, a dihydropyridine calcium  channel 
activator, is able to increase calcium  entry into sm ooth m uscle cells through L-type 
calcium  channels (Schram m  et a l., 1983) which may directly activate the contractile 
filam ents, or prom ote calcium -induced calcium  release (Ito et a l.,1991) which 
augm ents the increase in calcium  within the smooth muscle cell. Caffeine directly 
activates the ryanodine-sensitive calcium  release channel o f the sarcoplasm ic reticulum 
(SR), to prom ote calcium  release within the smooth muscle cell independent o f 
calcium  entry , (V an Breemen & Saida, 1989; W atanabe et a l., 1992). H ow ever, it 
can also prom ote relaxation in cells containing basal cA M P or cG M P levels, through 
an increase in intracellular cA M P and cG M P, via inhibition o f phosphodiesterase
(Butcher & Sutherland, 1962), to increase calcium  uptake by the sarcoplasm ic
2 +
reticulum  and enhance efflux via sarcolem m al Ca -A T Pase (Van Breem en & Saida,
1989). An increase in intracellular cA M P in smooth m uscle may also prom ote 
relaxation via a decrease in the sensitivity o f the contractile proteins in sm ooth muscle 
(K errick &  H oar, 1981). In vascular sm ooth m uscle, noradrenaline and m ethoxam ine
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can activate a \-ad ren o cep to rs  which leads to activation o f phospholipase C (PLC) via 
a G -protein, to prom ote hydrolysis o f phosphatidyl inositol (4,5) bisphosphate (PIP2 ), 
to form  inositol (1 ,4 ,5 ) triphosphate (IP3 ) and diacyl glycerol (DAG). This produces 
both an increase in calcium  release from the sarcoplasm ic reticulum , via the action o f 
IP3 on the calcium  release channel (IP3 receptor o f the sarcoplasm ic reticulum) and a 
phosphorylationof the contractile proteins following DAG activation o f protein kinase 
C (PKC) (N ishim ura et a l., 1989; Van Breem en & Saida, 1989; M organ & Suem atsu,
1990). Stim ulation o f a \-ad renocep to rs  may also prom ote calcium entry, through 
receptor operated (voltage-insensitive) calcium  channels (Van Breemen & Saida, 1989; 
Lee & Severson, 1994). PG F 2a -induced vasoconstriction has been reported to 
involve a sim ilar m echanism , ie. via activation o f phospholipase C (Hatanaka et a l., 
1989; Colem an et a l., 1994), following activation o f prostaglandin FP receptors, 
although throm boxane receptors could also be involved in PG F2a -induced 
vasoconstriction (Schror, 1993). A gonist-induced calcium  entry is generally regarded 
as a  m ore effective m echanism  for increasing intracellular calcium  in smooth muscle 
cells than depolarisation or direct activation o f calcium  channels, through an inhibition 
o f the 'buffer b a rrie r '. The buffer barrier describes a calcium  buffering process within 
sm ooth m uscle cells, w hereby calcium  entering the cell is taken up by the superficial 
sarcoplasm ic reticulum , to be extruded via the sarcolem m al C a^T -A T P ase  pum p, and 
N a + -C a ^ +  exchange. As agonists can increase calcium  release as well as calcium 
entry, they are m ore effective in increasing calcium  levels in the bulk o f the cytoplasm  
in sm ooth m uscle cells (Van Breemen & Saida, 1989; Nishim ura et a l., 1989; Sturek 
et a l., 1992). A low sodium  perfusate can also prom ote an increase in calcium  in 
vascular sm ooth muscle cells, producing vasoconstriction. A low sodium 
concentration outside the smooth muscle cell will favour calcium  influx and sodium  
efflux via the exchanger (Batlle et a l., 1991), and hence prom ote calcium -induced 
calcium  release from  the sarcoplasm ic reticulum  (Ito et a l., 1981), to provide the 
calcium  for activation o f m yofilam ents, and hence prom ote contraction. A high 
potassium  perfusate depolarises the cell w hich opens calcium  channels to prom ote 
calcium  entry. Hence, high potassium  facilitates the action o f calcium  antagonists, but
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above a certain threshold (approximately 40mM) of potassium, will prevent the action 
of vasodilators which act by opening potassium channels, due to a high degree of 
depolarisation of the smooth muscle cells and a reduction in the driving force for 
potassium efflux following potassium channel opening (Hamilton et a l., 1986).
In smooth muscle, the main trigger for contraction following a rise in intracellular 
calcium is by calcium binding to calm odulin, to activate myosin light chain kinase and 
trigger actin mediated hydrolysis of myosin Mg ATPase and cross-bridge cycling. 
However, in smooth muscle, contraction can occur in the absence of an increase in 
intracellular calcium, for example via PKC-induced phosphorylation o f myosin light 
chain, which contributes to the a r adrenenoceptor mediated vasoconstriction (Walsh, 
1990; M organ & Suematsu, 1990). The pathways involved in smooth muscle 
responses to the agents used in this study are outlined in Figure 5a.
F igure  5a
D ifferen t m echanism s of con traction  w ith in  sm ooth m uscle cells, e licited  by the  
com pounds used in th is study .
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8.2 Mechanisms of increasing cardiac muscle contractility.
In the m yocardium , the same agents can increase contractility in the following ways. 
The calcium  channel activator BAY K 8644 can increase calcium entry through L- 
type calcium  channels in cardiac m uscle (Thomas et a l., 1985) and hence prom ote an 
increase in calcium -induced calcium  release from the sarcoplasm ic reticulum  
(Fabiato, 1983; Rich et a l., 1988). N oradrenaline can increase force o f contraction 
by sim ilarly  increasing calcium  curren t through L-type calcium  channels. In this 
case, this follows (3x-adrenoceptor stim ulated Gs-protein activation o f adenylate 
cyclase and a subsequent increase in intracellular cA M P. This activates protein 
kinase A, which phosphorylates L-type calcium  channels to increase the probability 
o f opening (Sperelakis, 1988; Robishaw & Foster, 1989). Protein kinase A can also 
increase the rate o f relaxation o f cardiac m uscle both via increasing the rate o f uptake 
o f calcium  into the sarcoplasm ic reticulum  via phosphorylation o f phospholam ban, 
which rem oves the inhibitory action o f  phospholam ban on the sarcoplasm ic reticulum 
Ca +  -A TPase pum p (Kranias, 1985), and also via phosphorylation o f the 
m yofilam ents to increase cycling rate (Strang et a l., 1994). In the whole heart, the 
increase in cA M P is also able to activate the pacem aker current If, carried by sodium 
and potassium  ions in sino-atrial node cells (D ifrancesco, 1993), and hence increase 
heart rate, m ainly via a direct effect o f  cA M P rather than via protein kinase A- 
induced phosphorylation (D ifrancesco & T ortora, 1991; Difrancesco & M angoni, 
1994). A direct G s protein pathway for the activation o f If current, following 11- 
adrenoceptor stim ulation has also been proposed (Yatani et a l., 1990). The 
m echanism  by which m ethoxam ine, via cq  -adrenoceptor stim ulation, prom otes an 
increase in force o f contraction o f cardiac m uscle has not yet been fully established, 
but is thought to be independent o f a  rise in intracellular calcium (Puceat et a l.,
1992). T he a i-adrenoceptor mediated PIP2 hydrolysis, as described above for 
sm ooth m uscle, results in form ation o f IP3 and DAG (Brown et a l., 1985).
H ow ever, IP 3 is not thought to have an im portant role in m yocardial contractility 
(W oodcock et a l., 1987; Langer, 1992). DA G -activated protein kinase C, however,
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is thought to increase myocardial contractility, both via direct phosphorylation of 
contractile proteins to increase the sensitivity to calcium  (Puceat et a l., 1990), and 
via intracellular alkalisation by phosphorylation o f the sarcolem mal N a+ -H +  
exchanger to prom ote H +  efflux (Gambassi et a l., 1992; Fedida et a l., 1993). 
Prostaglandin F2a , which has also been shown to increase myocardial contractility 
(K arm azyn et a l., 1981) may also produce a sim ilar effect, as the effector mechanism 
is v ia phospholipase C, and PIP2 hydrolysis (H atanaka et a l., 1989; Coleman et a l., 
1994). H ow ever, PG F2a  has also been reported to inhibit Na +  -K + ATPase 
(K arm azyn et a l., 1981), and thus may produce an increase in contractility via a 
sim ilar m echanism  to the cardiac glycosides, via increased calcium entry through 
reverse N a + -C a ^ -*" exchange, and subsequent release o f calcium from the 
sarcoplasm ic reticulum  (Kohmoto et a l., 1994). A low sodium perfusate can increase 
m yocardial contractility  in a sim ilar m anner to the m ode o f action described for the 
sm ooth m uscle contraction (see above), ie. an increase in calcium  influx via the 
exchanger and calcium -induced calcium release from  the sarcoplasm ic reticulum  
(Leblanc & H um e, 1990, Kohmoto et a l., 1994). C affeine can produce a direct 
activation o f the ryanodine sensitive calcium  release channel (Rousseau & M eissner, 
1989), as well as an increase in m yofilam ent responsiveness to calcium , and an 
increase in calcium  entry following phosphorylation o f  L-type calcium channels 
follow ing an increase in intracellular cA M P, through an inhibition of 
phosphodiesterase (Bers, 1985), assum ing basal levels o f cAM P to be present.
The m ain trigger for contraction in cardiac m uscle, following a rise in intracellular 
calcium , is calcium  binding to troponin C , which shifts troponin I and tropom yosin 
relative to actin to perm it actin to cross-bridge m yosin, with the hydrolysis o f 
m yosin M gA TPase and the production o f  force (Langer, 1992). Unlike smooth 
m uscle, force is only produced in the presence o f an increase in intracellular calcium , 
although phosphorylation o f contractile proteins eg. by PKC can increase the 
sensitivity  o f  the m yofilam ents to calcium , and hence increase force o f contraction. 
The m echanism s by which the agents used in this study can increase myocardial 
contractility  are outlined in Figure 5b.
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Figure 5b.
T he d iffe re n t m echanism s of increasing m yocard ial co n trac tility , elicited by the 
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This study investigates the interaction o f the coronary dilator P IP i with the above 
agents in isolated perfused hearts, isolated left atria and isolated myocytes, in order to 
elucidate the mechanisms of action o f P IP i within coronary smooth muscle and 
cardiac muscle. It also investigates structure-activity relationships of coronary dilator 
acyl carnitine derivatives using the isolated, perfused rat heart model, as discussed 
above. In addition, the effects of the coronary dilator P IP i on a model of ischaemia / 
reperfusion, using the isolated, perfused rat heart were studied, in order to investigate 
a possible protective role.
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Methods 
1. Isolated perfused rat heart (Langendorff) technique.
M ale W istar rats (270-320g) w ere anaesthetised with sodium pentobarbitone (60m g/kg
i.p .) and the hearts excised and perfused at lOm l/m in, 37°C  using a m odified 
L angendorff technique. The K rebs-H enseleit solution used was o f the following 
com position (m M ):-
NaCl: 118
N a H C 0 3 : 25








C aC l2 : 2.4
H earts w ere perfused via the coronary vessels, following retrograde perfusion o f the 
aorta. T he experim ental setup for this technique is shown in F igure 6 .
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Figure 6
The isolated perfused rat heart (Langendorff) technique, for the measurement of 
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In preparations in which coronary dilator responses were m easured, after 20 minutes 
o f perfusion  the perfusate was switched to one containing 2mM  KC1 ie. the total K +  
concentration was reduced from 5.9m M  to 3 .2m M . This had the effect o f raising the 
coronary  perfusion pressure by an average o f  27m m H g; from  7 0 ± 2 .9 m m H g  to 
9 7 + 2 .6 m m H g , n = 6 9 , to allow greater scope for the coronary dilator responses. 
C oronary  perfusion pressure was m easured using a Gould pressure transducer attached 
to a side arm  on the aortic cannula, developed tension was recorded under a  resting 
tension o f 2g via a hook placed in the apex o f the heart, connected to a Devices 
isom etric transducer. The tension recording triggered a Gould rate m eter to give a 
concurren t heart rate record. All recordings were made on Gould 3400/2400 
recorders and drugs were added either as perfusions or in volumes o f no m ore than 
30/zl v ia an injection port on the aortic cannula.
1.1 Structure-activity relationship studies on novel synthetic acyl carnitine 
derivatives.
Follow ing a 20 m inute equilibration period, the K +  concentration o f the K rebs- 
H enseleit solution was switched to 3 .2m M . The potencies o f several structural 
derivatives o f palm itoyl carnitine were com pared with the prototype coronary dilator 
derivative, the isopropyl ester o f palm itoyl carnitine (P IP i). Therefore a submaximal 
dose (0.3nm oles) o f P IP i was first adm inistered to the preparation. The preparation 
was allow ed to recover before constructing a dose-response curve to the com pound 
under investigation, allow ing the preparation to recover betw een each addition.
1.2 Effect of verapamil on the response to Compound G.
H earts w ere set up as described above, and the same protocol repeated using one o f 
the synthetic derivatives o f palm itoyl carnitine, compound G (table 1, results), as the
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com pound under investigation. H ow ever, in these experim ents lOOnM verapam il was 
perfused p rior to the addition o f the 0 .3nm ole P IP i standard and was present for the 
duration o f  the experim ent.
1.3 Effect o f llO m M  K + perfusion on responses to PIPi, verapamil, papaverine, 
salbutam ol, nicardipine and lemakalim, and the effect o f 20mM K +  perfusion on 
responses to PIPi and verapamil.
Follow ing equilibration in 3 .2m M  K +  K rebs-H enseleit, a bolus dose o f  0 .3nm oles 
P IP i was adm inistered, and follow ing recovery , a bolus sub-m axim al dose o f another 
coronary  dilator was adm inistered (verapam il 1 nm ole, papaverine 30nm oles, 
salbutam ol 50nm oles, lem akalim  lOnmoles or nicardipine 0.5nm oles). This process 
was repeated before perfusing a m odified K rebs-H enseleit solution, in which the 
potassium  chloride concentration had been increased to 108.8mM ie. 1 lOmM K “*~ in 
total. T he sodium  chloride concentration was reduced to 13.9mM  to m aintain 
osm olarity . The sam e doses o f P IP i and the other coronary  dilator used were then 
repeated in the presence o f llO m M  K +  . In the case o f 20m M  K +  experim ents, the 
sam e protocol was repeated using a m odified K rebs-H enseleit containing 18.8m M  
KC1, 103 .9m M  NaCl ie. 20m M  K +  , in p lace o f llO m M  K +  . In these experim ents, 
the effect on P IP i and verapam il responses only were exam ined.
1.4 Effect o f tetraethylammonium chloride (TEA) on responses to PIPi.
Hearts w ere equilibrated in 3 .2m M  K +  and single doses o f verapamil (1 nmole) and 
P IP i (1 nm ole), as control responses, w ere adm inistered before a concentration o f 
lOmM TEA  was perfused through the preparation  for 20 minutes. A bolus dose o f 
1 nm ole verapam il was repeated in the presence o f  the TEA  before constructing a dose- 
response curve to P IP i in the presence o f  TE A .
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1.5 Effect of PIPi, palmitoyl carnitine, atenolol or polymyxin B on the developed 
tension, heart rate and perfusion pressure responses to BAY K 8644, 
noradrenaline, PGF2 a , methoxamine or caffeine.
These experim ents w ere conducted in the presence o f a 5 .9m M  K +  perfusate 
throughout. Follow ing 20 minutes equilibration a dose-response curve to bolus doses 
o f BA Y  K 8644, noradrenaline, PG F2 a , m ethoxam ine or caffeine was constructed, 
allow ing the preparation to recover betw een each dose. A t the end o f the initial dose- 
response curve, a concentration o f P IP i, palm itoyl carnitine, phentolam ine, atenolol 
or polym yxin B was perfused for 20 m inutes before repeating the dose-response curve 
in the presence o f the perfused com pound.
In the case o f  BAY K 8644 experim ents, further dose-response curves were 
constructed at 20 m inute intervals in the presence o f increasing concentrations o f P IP i 
(lOnM  to In all cases, tim e-m atched dose-response curves w ere repeated in the
absence o f  any com pound being perfused. In the case o f the m ethoxam ine 
experim ents, only one dose-response curve was constructed in each experim ent, either 
in the presence or absence o f P IP i, due to the tachyphylaxis shown with this 
com pound.
1.6 Effect of noradrenaline following washout o f PIPi (reversibility experiments).
In experim ents to investigate the reversibility  o f the action o f P IP i on the 
noradrenaline-induced responses, hearts w ere perfused with 5.9m m  K +  Krebs- 
H enseleit and follow ing 20 minutes equilibration, a single subm axim al dose o f 
noradrenaline (1 nm ole) was added. This dose was repeated after perfusing P IP i 
through the preparation for 20 minutes. T he P IP i was washed out for 40 minutes 
before applying the sam e dose o f noradrenaline for a third time.
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1.7 Effect o f increasing heart rate by electrical pacing in the isolated perfused 
heart on developed tension and perfusion pressure.
H earts w ere set up in 5.9m M  K +  K rebs-H enseleit solution, and allowed 20 m inutes to 
equilibrate. An electrode was placed on the right atrium  and another on the aortic 
cannula, connected to a Grass SD 9 stim ulator. A threshold voltage was established 
and the voltage was then set 50%  above this, pulse width 1ms. Hearts w ere stim ulated 
first at 330bpm  for 30 seconds, and allow ed to recover. H eart rate was subsequently 
increased to 360, 390, 420, 450bpm  allow ing the preparation to recover betw een each 
period o f stim ulation.
1.8 Effect o f lowering the concentration o f sodium chloride in the Krebs-Henseleit 
perfusate on developed tension, heart rate and perfusion pressure, and the effect 
of P IP i on the response to a low (59mM) concentration of NaCl in perfusate.
H earts w ere set up as previously described. In order to establish a concentration o f 
sodium  chloride producing a subm axim al response in term s o f myocardial 
contractility , a concentration-effect curve to the sodium  chloride concentration o f  the 
K rebs-H enseleit perfusate, starting at a baseline o f 118mM (normal Krebs) and being 
reduced to 89, 59 & 44m M  respectively at five m inute intervals, was constructed. 
Isotonicity was m aintained by the addition o f  0, 59, 118 & 148mM sucrose 
respectively.
F urther experim ents were subsequently  carried  out using 59rnM  NaCl, isotonicity 
being m aintained by the addition o f  sucrose (118m M ). In these experim ents, the low 
sodium  perfusate was perfused for 5 m inutes before returning to the normal perfusate. 
This was repeated three times at 20 m inute intervals. In the control experim ents it was 
found that the second and third application o f  the low sodium  perfusate produced
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responses which were not significantly d ifferent from each other. T herefore in test 
experim ents P IP i was perfused for 20 m inutes between the second and third low 
sodium  periods, com parisons being made with the second and third low sodium  
periods in tim e-m atched controls.
1.9 Effect o f PIPi or palmitoyl carnitine on the effects o f 3x 20 minutes zero flow, 
global ischaemia / reperfusion in the isolated heart.
H earts w ere set up in 5.9m M  K +  m odified K rebs-H enseleit, with l lm M  glucose in 
Krebs replaced by 2m M . This concentration o f glucose was selected as it had been 
previously  been show n by our laboratory to be the threshold concentration for ATP 
depletion and ischaem ic contracture in a m odel o f 20  m inutes ischaemia / 20  minutes 
reperfusion, and thus a graded effect on the effects o f each 20  m inute period o f 
ischaem ia and reperfusion could be obtained. Follow ing a 20 minute period o f 
equilibration , hearts were subjected to 20 m inutes zero flow global ischaem ia. The 
preparation  was kept warm by means o f a heating jacket m aintained at 3 7 °C. 
Follow ing this period flow was resum ed, and after 20 m inutes o f reperfusion the 
w hole process was repeated. The whole process was repeated for a third tim e. In 
separate experim ents, a concentration o f P IP i or palm itoyl carnitine was included in 
the perfusate throughout.
2. The isolated stimulated left atrium of the rat.
M ale W istar rats (270-320g) were anaesthetised with sodium  pentobarbitone (60m g/kg 
i.p .)  and the hearts rem oved. The left atrium  was isolated and a thread was tied at 
each end. O ne end was tied directly to a w ire electrode and the other attached via a 
thread to a D evices isom etric transducer. T he whole preparation was placed in a 30ml 
organ bath containing 5.9m M  K +  K rebs-H enseleit solution (as previously described)
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containing 100/*M ascorbic acid to prevent oxidation o f the added noradrenaline, 
gassed with 95% 0 2 / 5 % C 02- The preparation was placed under a resting tension 
o f 500m g and was stim ulated at 50% above the threshold voltage ie. 40-60v, 1ms 
duration and at a frequency o f 0 .5H z, via an electrode adjacent to the m uscle and 
another field electrode placed above the preparation. A tria were stim ulated using a 
Grass SD 9 stim ulator. Each preparation was allowed 1 hour to equilibrate follow ing 
which a steady twitch was m aintained. D eveloped tension recordings w ere m ade on a 
Lectrom ed chart recorder.
2.1 Effect o f PIPi on the response to noradrenaline in the isolated left atrium, 
stimulated at 0.5H z.
A cum ulative concentration-effect curve to noradrenaline was constructed starting at 
lOOnM. The responses were allowed to plateau before the next addition o f 
noradrenaline. The noradrenaline was then com pletely washed out o f the tissue and 
the preparation  allowed 20 minutes to recover. The concentration-effect curve was 
repeated in the sam e preparation in order to check for reproducibility. The tissue was 
w ashed and in test experim ents a concentration o f P IP i was added to the organ bath 
and left for 20  m inutes before repeating the noradrenaline concentration-effect curve.
In tim e-m atched control experim ents, a third concentration-effect curve was 
constructed in the absence o f P IP i.
2.2 Effect o f PIPi on the duration o f the twitch response in the isolated, 
stimulated left atrium in the presence of noradrenaline.
Left a tria  w ere set up as described previously. Follow ing a 30 m inute equilibration 
period , the chart speed was increased from  2 .5m m /m in  to lOOmm/sec in order to 
m easure the duration o f  the twitch response. One peak was recorded before returning
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the chart speed to 2 .5m m /m in. This process was repeated in the presence o f 3/xM 
noradrenaline. The noradrenaline was washed out and the preparation incubated with 
a concentration  o f P IP i before repeating the process in the presence o f P IP i. Tim e- 
m atched controls w ere perform ed in the absence o f  P IP i.
3. Technique for the isolation of rat ventricular myocytes.
M yocytes w ere isolated using a m odification o f  the m ethod described by Pow ell & 
T w ist (1976). M ale W istar rats were anaesthetised with 60m g/kg sodium 
pentobarb itone and the hearts excised and perfused in a non re-circulating system  at 
lO m l/m in using a calcium  free salt solution o f  the follow ing com position (m M ):- NaCl 
118.5, N a H C 0 3 14.5, KC1 2 .6 , KH 2 P 0 4 1.18, M g S 0 4 1.18, L-glucose 11.1 to pH 
7 .4 , bubbled w ith 95% 0 2 , 5% C 0 2 . The solution was m ade up using m illi-Q  
w ater. The heart was perfused in a non-circulating system  until the blood was 
rem oved from  the coronary vasculature and this perfusate was discarded. The volum e 
o f perfusate  was adjusted to 40ml and this was allow ed to re-circulate the heart. 
Follow ing 5 m inutes o f total perfusion tim e, 20m g C ollagenase type II, dissolved in 
10ml o f  the salt solution described above, plus 25juM C aC l2 were added to the re ­
circu lating  solution. Therefore, a final volum e o f 50ml collagenase solution was re ­
circu lated . A fter 20 minutes o f enzym ic digestion the heart was cut down, the atria 
rem oved and the ventricles chopped into four pieces using a scalpel and teased apart 
using forceps. The tissue was then incubated for 10 m inutes at 37°C  in 20m l o f the 
re-circu lating  solution bubbled with 95% 0 2 , 5% C 0 2 and triturated periodically with 
a pipette . A fter 10 minutes the m ixture was filtered through 250/^M nylon mesh gauze 
into a  centrifuge tube. The cells were spun at 300rpm  for 5 minutes and resuspended 
in the salt solution described above, containing m inim al (25juM) calcium . The cells 
w ere washed tw ice before being resuspended in 10ml solution (25/uM C a ^ + ), HEPES 
buffered  to pH  7 .4 . The cells were then ready to be loaded with fura-2AM  for 
fluorim etric  analysis.
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3.1 Method for the estimation of intracellular calcium in cardiac myocytes using 
the fluorescent indicator fura-2AM and fluorescence microscopy.
This technique, first described by Tsien at al. (1985), m easures changes in 
intracellular calcium within a single cell (m yocyte), so elim inating problem s arising 
from  heterogeneity in a population o f cells and the need to correct for signals arising 
from  extracellular dye, which occur in the cuvette system  (Li et a l., 1987). In 
addition, single myocytes could be superfused and electrically stim ulated whilst 
m easuring changes in intracellular calcium . The fluorescent C a ^ +  indicator fura- 
2A M , the acetoxymethyl ester o f fura-2 (G rynkiew icz et a l., 1985), was used. Upon 
de-esterification within the cell, fura-2 binds to C a2 +  , to increase the 510nm 
em ission from  an excitation wavelength o f  340nm  and decrease the emission from an 
excitation wavelength at 380nm , which can be used to estim ate the free calcium 
w ithin the cell (see later). This indicator is also very selective for C a^ -*" over other 
divalent cations which may be present in the intracellular environm ent (Grynkiewicz 
et a l., 1985).
The cells were divided into two aliquots o f  5 ml. One aliquot was refrigerated at 
4 °C  as reserve. To the rem aining 5 ml aliquot was added 2.5/^tM fura-2AM , the 
acetoxym ethyl ester o f fura-2, and 0.25%  BSA to aid loading. The tube was covered 
with alum inium  foil to prevent bleaching o f the dye, and cells were loaded for 30 
m inutes at 37°C . The cells were then spun at 300 rpm  for 5 minutes and 
resuspended in HEPES buffered salt solution containing 100/xM C a- +  . The process 
was repeated, increasing the calcium to 300juM and finally Im M . Calcium was 
added sequentially in order to prevent calcium  overload which can occur following 
rapid addition o f a high concentration o f calcium . The cells w ere then left for at 
least 30 minutes to allow intracellular hydrolysis o f the dye before being used for 
fluorim etry.
Apparatus for fluorescence microscopy technique. 
For fura-2 measurements.   uv (exitation) light
   fluorescence
Chopper wheel, allowing 
alternate 340nm & 380nm 
wavebands through (60Hz).
75W Xenon arc lamp Dual monochromators
lenses
silver-silver chloride electrodes, 
connected to Grass SD9 stimulator.
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M yocytes were left at room tem perature for at least 30 minutes in order to allow  for 
de-esterification o f the acetoxy methyl ester o f fura-2 within the cells. They were then 
placed on a glass coverslip, which form ed the base o f a perspex superfusion cham ber, 
and w hich had been pretreated in order to optim ise cell adhesion as follow s:-
The coverslip  was washed, first in alcohol then distilled w ater, and then polished. A 
solution o f  15/xg/ml lam inin (from basem ent m em brane m ouse sarcom a) in HEPES 
buffered  salt solution (500ml) was incubated with the coverslip for 1 hour at room  
tem perature. The cham ber was then washed thoroughly with fresh HEPES buffered 
salt so lution, and the cham ber was left filled with HEPES buffered salt solution until 
use to prevent the laminin drying. The cham ber was placed on the stage o f a Nikon 
D iaphot inverted m icroscope so that the glass coverslip was in direct contact with the 
40x o il-im m ersion fluorescence objective. The m yocytes were left for ten m inutes to 
allow  for cell adhesion to the base o f  the superfusion cham ber before being superfused 
at 2m l/m in  with Im M  C a ^ T , HEPES buffered salt solution (see above for 
com position) at room  tem perature. The cells were perfused throughout these 
experim ents, to ensure that the concentrations o f agonist /  antagonist reaching the 
m yocytes was know n, as passive diffusion follow ing a bolus addition o f agonist / 
antagonist may result in an non-uniform  concentration o f drug reaching the m yocyte 
under investigation. The cells were stim ulated by means o f two silver-silver chloride 
electrodes, placed at opposite ends o f the superfusion cham ber, attached to a Grass 
SD 9 stim ulator. M yocytes were stim ulated at 1Hz, 1ms pulse width, and 
approxim ately  50%  above the threshold voltage, usually 40-60v. For each experim ent 
a single m yocyte was selected using the follow ing criteria :- Clear cross striations, rod 
shaped with jagged not rounded ends, quiescent prio r to electrical stim ulation, but 
show ing a consistent contraction in response to each electrical stim ulus, well adhered 
to the coverslip  and finally well and evenly loaded with fura -2 (see below ).
By diverting  the path o f light from the objective to a side arm  o f the m icroscope, a 
single m yocyte could be isolated by means o f  vertical and horizontal shutters on the
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m icroscope (see Figure 7). The fura-2 loaded m yocyte was superfused and 
electrically  stim ulated throughout the experim ent. Follow ing approxim ately 5 
minutes superfusion, a UV light source from a 75W  arc lamp was passed through the 
objective to the cell under investigation. This had the effect o f exciting the fura-2 
within the cell causing it to emit light in the visible spectrum  ie. fluoresce. Only 
cells that w ere visibly and evenly fluorescent were selected for use. The UV light 
source consisted o f two wavebands o f 340 and 380nm  from  a dual m onochrom ator 
illum inator source, and these wavebands were transm itted alternately by means o f a 
chopper rotated at 60FIz. The alternating UV wavelengths were transm itted to the 
m yocyte under investigation via a flexible light guide and were reflected o ff a 
dichroic m irror before being passed through the oil im m ersion objective to the glass 
coverslip holding the myocyte. The resultant fluorescence was transm itted to a 
photom ultiplier tube via a series o f lenses and m irrors, and finally to the detector. A 
510nm  filter ensured that only fluorescence o f approxim ately that waveband was 
detected. Prior to m easurem ent o f fura-2 fluorescence within the m yocyte, a 
background fluorescence was taken. This was done by m oving the m icroscope stage 
so that the shutters enclosed an area where no m yocytes w ere in view. The 340 and 
380 signals were measured in the same way as w ithin the myocyte. The voltage on 
the detector was then set, in order to obtain a background count o f the order 1(P  
photons, usually approxim ately 510 volts. PTI deltascan software autom atically 
subtracted these background levels whilst collecting and interpreting data from the 
fura-2 signals produced by the myocyte. W ith increasing calcium within the cell, the 
em ission at 510nm  from the excitation wavelength o f 340nm  (1A) will increase, and 
from  the excitation wavelength o f 380nm (2A) the em ission at 510nm  will decrease. 
Hence the 340/380 signal ratio is a function o f the concentration o f free calcium  
within the cell. The signal ratio was m easured, as opposed to ju st the em ission from 
an excitation wavelength at 340nm as this allows an estim ation o f the calcium  
concentration within the cell independent o f cell loading. Additionally, it elim inates 
changes in the signal occurring as a result o f  changes in intensity o f the excitation 
light, leakage or bleaching o f the intracellular dye, all o f  which could be interpreted
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as a decrease in intracellular calcium , as this will cause a decrease in both the 1A and 
2A signal. It also eliminates changes occurring due to cell 'thickening' occurring 
during a tw itch, as this will cause an increase in both the 1A and 2A signal 
(Capogrossi & Lakatta, 1989). This ratio was sampled 60 times every m inute, the 
rate being controlled by the rate o f rotation by the chopper. 340/380 signal ratios 
were used to give an estimate o f relative changes in calcium concentration within the 
m yocyte.
The concentration o f calcium within the cell was not calibrated due to the well 
established difficulties with this technique ie. ion binding and spectral behaviour in 
the intracellular environm ent (Capogrossi & Lakatta, 1989; Frampton et a l., 1991) 
and incom plete hydrolysis o f ester groups within the cell, leaving calcium  insensitive 
species (Scanlon et a l., 1987), and spectral interference with intrinsic fluorescent 
com pounds such as NA DPH (Koretsky et a l.,1987). Even using intracellular 
calibration creates difficulties in the case o f  myocytes, due to the hypercontracture 
which develops on exposure to saturating levels of calcium (Li et a l., 1987; Borzak 
et a l., 1991) and com partm entalisation o f  the dye into intracellular organelles eg. 
m itochondria (Steinberg et a l., 1987), w hich may produce a false indication o f 
cytosolic free calcium . Additionally, we w ere interested in seeing changes in the 
peak heights o f calcium  oscillations in response to agonists rather than actual calcium 
concentrations.
Typically, signals o f between 10^ and 10^ counts per second were obtained for the 
1A and 2A signals, representing the em ission at 510nm  from  excitation wavelengths 
of 340nm  and 380nm  respectively ie. approxim ately 10 times above the background 
signal. An estim ate o f intracellular free calcium  was obtained by obtaining the 
340/380 signal ratio, which is directly proportional to the calcium concentration 
within the m yocyte. The calcium  transients in response to electrical stim ulation at 
1Hz varied greatly  in different individual m yocytes, probably due to differences in 
cell size and original location within the ventricles. Therefore a large sam ple num ber
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was obtained for each experim ent in order to estim ate the average increase in the 
340/380 signal ratio in response to electrical stim ulation at 1Hz. In order to 
standardise the experim ents, data representing the mean o f all cells under 
investigation was obtained from the mean o f  five peaks from the 50-55 seconds 
interval on the time scale for each myocyte. Responses in the presence o f agonist 
were m easured at 150-155 seconds on the tim e scale.
3.1.1 Effect of noradrenaline, verapamil or caffeine on the 340/380 fura-2 signal 
ratio increase in response to electrical stimulation at 1Hz in a single myocyte.
Cells w ere isolated, loaded with fura-2AM  and prepared for fluorim etry as described 
above. Cells were allowed to settle for 10 m inutes then perfused and stimulated at 
1Hz, as described above, for another 5 m inutes before any fluorim etric 
m easurem ents were taken. Following this, the illum inating UV source was 
deflected, to illum inate the myocyte under investigation (this was left until just before 
m easurem ent to prevent bleaching o f the dye) and m easurem ent comm enced. Basal 
340/380 signal ratio oscillations were taken for 1 m inute prior to the addition of 
noradrenaline, verapam il or caffeine. Follow ing this, a concentration of 
noradrenaline, verapam il or caffeine was included in the perfusate and measurem ent 
was continued for 3 minutes. After m easurem ent, the superfusion chamber was 
washed thoroughly and a new batch o f cells w ere used for each subsequent 
experim ent.
3.1 .2  Experiment to investigate the direct effect of PIPi on the 340/380 signal 
ratio increase in response to electrical stimulation at 1Hz in a single myocyte.
Separate experim ents were carried out to discover w hether P IP i had a direct effect 
on m yocytes. The cham ber was superfused with HEPES buffered salt solution in the 
absence o f P IP i for 5 minutes, as described previously and a 340/380 signal ratio
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m easurem ent taken, before adding a concentration of P IP i to the perfusate. The 
preparation was superfused for 5 minutes in the presence o f P IP i before a 
m easurem ent o f the 340/380 signal ratio in the presence o f P IP i was taken.
3.1.3 Effect of noradrenaline in the presence of PIPi or atenolol on the 340/380 
signal ratio increase in response to electrical stimulation at 1 Hz in a single 
myocyte.
These experim ents were carried out using a sim ilar protocol to that described in 
section 3 .1 .1 , except cells were superfused for 5 minutes prior to the com m encem ent 
o f fura -2  m easurem ent, and throughout the experim ent, in the presence o f a 
concentration o f  P IP i or atenolol. The tim e course o f the experim ent was therefore 
kept the sam e. The same protocol was used to investigate the effect o f P IP i on 
caffeine responses.
47
4. Drugs and materials.
P IP i and all synthetic derivatives o f palm itoyl carnitine were synthesized by M. Rad- 
N iknam  and G .H . Dewar in the School o f Pharm acy and Pharm acology laboratories, 
U niversity o f Bath.
Palm itoyl carnitine, isobutyl methyl xanthine (IBM X), sodium  nitroprusside, 
papaverine, tetraethylam m onium  chloride (TEA), atenolol, polym yxin B, 
prostaglandin  F2a  (PG F2a ), isoprenaline, caffeine, m ethoxam ine, noradrenaline, 
bovine serum  album in (BSA) and lam inin (basal m em brane mouse sarcom a). All 
purchased from  Sigma.
Also used : Verapam il (Abbot), salbutam ol (Allen and H anbury), lemakalim 
(Sm ithK line Beecham ), nicardipine (Syntex), BAY K 8644 (Bayer), collagenase type 
II (W orthington), fura-2AM  (M olecular probes).
All com pounds were first dissolved in 0 .9%  saline or PSS except BAY K 8644, 
IBM X, fura-2A M  (DM SO), PG F2 a  (ethanol) and lem akalim  (6 6 % ethanol, 
3 3 %H2 0 ) subsequent dilutions being m ade in saline / PSS. All solutions of 
noradrenaline had lOO^M ascorbic acid added to prevent oxidation.
5. Statistical analysis.
All data is expressed as m ean+ sem .
D ifferences betw een means were assessed using either a paired or unpaired Student's 
t-test, or a one or two way analysis o f variance (ANO VA ) followed by a Studentised 
range test o r D unnett’s test, as appropriate. A p value o f  less than 0 .05 was 
considered significant (indicated by * on figures).
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Results
1.1 Structure-activity relationship studies on novel synthetic acyl carnitine 
derivatives.
Structure-activity  relationship studies w ere carried out in order to elucidate which 
groups o f the m olecule o f the coronary dilator derivatives o f palm itoyl carnitine are 
im portant in eliciting the coronary dilator activity, ie. whether the positive charge on 
the quaternary nitrogen or the ester grouping attached at the C term inus o f the 
carnitine m oiety are im portant in eliciting a coronary dilator response.
For all the structure-activity relationship studies com bined, the perfusion pressure in 
the presence o f  5 .9m M  K +  K rebs-H enseleit was 7 0 ± 2 .9 m m H g , n =  69. On 
sw itching to m odified K rebs-H enseleit containing 3.2m M  K + , the perfusion pressure 
increased to a mean o f  9 7 + 2 .6 m m H g  ie. an average increase in perfusion pressure o f 
27m m H g. This allowed a greater scope for coronary dilator responses to be seen.
1.1.1 Effect of removing the terminal ester group on coronary dilator activity.
The isopropyl ester o f palm itoyl carnitine (P IP i) differs from  the parent com pound 
palm itoyl carnitine by the presence o f an isopropyl ester group in place o f  a carboxylic 
acid group on the term inal carbon (Table 1). W hereas palm itoyl carnitine is a potent 
constrictor in the coronary vasculature (C riddle et a l., 1990) it can be seen from 
Figure 8 that P I Pi is a potent vasodilator. Figure 8 is a typical trace showing the 
effect o f P I Pi on perfusion pressure in the isolated perfused heart preparation in the 
presence o f 3 .2m M  K +  . Bolus doses o f P I Pi produced a long lasting coronary dilator 
effect, the m axim um  dilation being produced at 3nmoles. There was no concom itant 
effect on developed tension or heart rate.
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Figure 9 is a representative trace showing the effect o f compound A, which has a 
sim ilar structure to PI Pi but with an ethyl group in the place o f the isopropyl ester 
grouping  (Table 1), on perfusion pressure in the presence o f 3.2m M  K~*~. It can be 
seen that this com pound also produces coronary dilation in the Langendorff isolated 
perfused heart. In addition, this com pound produced a transient variable coronary 
constric tion  preceding the coronary dilator effect. F igure 10 com pares dose response 
curves to P I Pi and Com pound A. It can be seen from  this graph that at lower doses 
(up to 3nm oles) Com pound A produced significantly (p < 0 .0 5 )  sm aller coronary 
d ila tor responses than P IP i. However, on com paring ED 5 q ’s and maximum  
coronary  dilator responses (Table 3), there was no significant difference between 
P IP i and Com pound A. However, it is clear from Figures 8 and 9 that bolus doses 
o f P I  Pi produced a longer lasting coronary dilator effect than Com pound A.
Table 1
Structures o f  the palmitoyl carnitine derivatives used in this study.
Palmitoyl carnitine Palmitoyl carnitine Isopropyl ester (PIPi)
C H - NC H - N
Compound A
C H - N
PALM
Compound B
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Trace showing the effect of bolus doses o f  PIP i on coronary perfusion pressure in the 













Trace showing the effect of bolus doses o f  compound A on coronary perfusion 





























Fig ure  10
T h e  ef fect  o f  P I P i  and Com pound A (see Table  1) on  perfusion  pressure in the 
isolated per fused  rat heart.  Data expressed as % relaxat ion f rom basal (elevated) 
per fus ion  pressure.
Basal per fus ion  pressure:  P IP i  114 +  3 . I m m H g  n = 4 ;  Co m p o u n d  A 1 0 1 ± 4 . 1 m m H g  
n =  4. * p < 0 . 0 5 ,  S tudent ' s  unpaired t-test.
O O Compound  A n = 4 




1.1.2 Effect of N terminus substitution on coronary dilator activity.
Figure 11 and Table 2 compare the potencies of compounds all containing the same 
C terminus substitution (ethyl group) but differing in their N terminus substitution. 
The ED 5 o ’s and maximum dilator responses were all compared with Compound A, 
with three methyl groups attached to the nitrogen, used as a reference compound. 
Com pound C, containing three ethyl groups attached to the nitrogen, was 
significantly more potent than Compound A (indicated by a significantly lower ED50 
; p < 0 .0 5 ) .  Compound B, containing two methyl groups and a hydrogen, was both 
significantly less potent and less effective than Compound A (indicated by a 
significantly higher ED 50  and significantly lower maximum dilator response 
(p < 0  .05). Compound D, containing three propyl groups at the N terminus, was not 
significantly different to Compound A in terms o f  potency or maximum dilation 
achieved.
It can also be seen from Figure 11 and Table 2 that Compound F, containing a 
morpholinyl ring in place of alkyl groups at the N terminus (Table 1) is the least 
potent compound of  all. An ED50  was not obtainable for this compound due to 
much variability in the dilation achieved in different preparations. However, the 
maximum dilator response was significantly lower than that of Compound A. 
Compound E contains an uncharged terminus nitrogen, due to only two methyls 
being attached (Table 1). It can be seen from Figure 11 that this compound is 
completely inactive as a coronary dilator, and produced a variable constrictor 
response only. All compounds tested showed a transient coronary constrictor 
response preceding dilation, similar to that seen for compound A in Figure 9.
Table 2 .
Effect o f N  terminus (Rj, R2 & R3 ) substitution on vasodilator activity, while keeping C terminus constant, (ILj-Et).
Comp. n= r 4 R i r 2 R3 Basal pp 
(mmHg)
ED 5 0  nmol. M ax % Dil. (Dose)
A 4 Et Me Me Me 101±4.1 1.06±0.07 36±1.8 (lOnmol)
B 4 Et H Me Me 78±8.8 12.8±2.5* 15±1.4 (30nmol)*
C 4 Et Et Et Et 83±10.6 0.26±0.09* 35±8.0 ( 1  nmole)
D 4 Et Pr Pr Pr 117±6,6 0.60±0.13 36±3.7 (lOnmol)
E 6 Et Me Me — 110±10.7 —  . INACTIVE
F 4 Et H 0 109±8.3 — 10±3.3 (lOOnmol)*
For ED 5 0  and Max % Dil. *p<0.05,. compared with Compound A (1  way ANOVA, followed by Dunnett’s test, for many comparisons to 
Control group, ie. Compound A).
Max % Dil.= The % relaxation from basal perfusion pressure at the optimal dose.
Me=methyl
Et=ethyl R 3
Pr=isopropyl | ^ / R 4  (N.B. Compound E is uncharged)
























Graph comparing the coronary dilator potencies o f Compounds A, B, C, D, E, F (see 
Tables 1 & 2), differing in their N terminus substitution, in the isolated perfused rat 
heart. Data expressed as % relaxation from basal (elevated) perfusion pressure.
(See Figure 12 for basal perfusion pressures).
O  O Compound A
•  —  •  Compound B
A —  A Compound u 
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1.1.3 Effect of C terminus substitution on coronary dilator activity.
Table 3 and Figures 12a & 12b illustrate the effect of C terminus substitution on 
coronary dilator activity, whilst keeping the N terminus constant ie. three methyl 
groups. All compounds were compared with Compound A, containing an ethyl 
group at the C terminus, in terms o f  ED5 0  values and maximum dilation achieved. 
All compounds containing the same N terminus and differing in their C terminus 
were equieffective in terms of maximum dilation achieved. In addition, C terminus 
substitution appeared to have a less profound effect on coronary dilator potency than 
N terminus substitution. However, Compounds G (hydrogen in place o f  a C 
terminus), J (containing a second quaternary nitrogen grouping), M and N 
(containing arginine and nitroarginine moieties respectively) were all significantly 
(p < 0  .05) less potent, indicated by higher E D 50  values (Table 3).
Compound L, an isomer o f  P IP i,  Com pound H, containing a methyl group at the C 
terminus, Compound I, containing a chloromethyl and Compound K, containing a 
thiol group were all found to be not significantly different to Compound A in terms 
o f  coronary dilator potency.
As for the compounds in Table 2, all the compounds in Table 3 showed a transient 
coronary constrictor effect preceding the coronary dilation. This was less marked in 
the case o f  P IP i  and its isomer Com pound L. Compound G containing a single 
hydrogen atom at the C terminus produced the greatest coronary constriction, 
producing at the optimum dose (30nmoles) a constriction of  24.7±5.3m m Hg (Figure 
14).
Table 3
Effect o f C terminus (R4 ) substitution on vasodilator activity, whilst keeping N 4- terminus constant (Rj, R2  & R3 = 3x Me).
Comp. n= r 1*r 2
& R 3
R , Basal pp 
(m m llg )
ED5 0  nmol Max % Dil (Dose)
A 4 3x Me Et 101 ±4.1 1. 1±0.07 36±1.8 (lOmnol)
PIPi 4 3x Me CH2 COOC3 H7 114±3.1 0.44±0.09 56±6.3 (3nmol)
G 6 3x Me H 95±5.6 5.4±1.0* 42±8.8 (30nmol)
H 6 3x Me Me 77±9.7 1.6±0.3 24±4.0 (lOnmol)
I 4 3x Me CH2 C1 88±6.5 2.9±1.0 37±4.5 (lOnmol)
J 3 3x Me CH2 N+Me U 3±14.8 8.5±3.1* 45±12.5 (lOOnmol)
K 4 3x Me c h 2sh 83± 11.1 3.3±1.3 27±8.6 (30nmol)
L 4 3x Me CH2 OCOC3 H7 102±10.9 0.58±0.03 42±5.4 (3nmol)
M 5 3x Me c h 2 c o - a r g 1 10± 8.6 7.1±1.4* 59±4.6 (30nmol)
N 5 3x Me c h 2 c o - n o a r g 96± 11.1 3.9±1.0* 41 ±4.9 (30mnol)
For E D 50  and Max %  Dil. *p<0.05,. compared with Compound A (1 way ANOVA, followed by Dunnett’s test, for many comparisons to one 
Control group, ie. Compound A).




























Graph comparing the coronary dilator potencies o f compounds differing in their C 
terminus substitution in the isolated perfused rat heart. Data expressed as % relaxation 
from basal (elevated) perfusion pressure.
Figure 12a: Compounds A,G,H,I. (See Tables 1 & 3).
Mean basal perfusion pressure for all compounds tested 96±2.6m m H g n = 69 .
o  o Compound A
• -----•  Compound G
a  —  a  Compound H 
a  a  Compound 1

































G ra ph  co m p ar i n g  the coronary dilator potencies o f  c o m p o u n d s  d i f fer ing in their C 
te rminus  subst i tut ion in the isolated perfused rat heart.  Data expressed as % relaxation 
f rom basal  (elevated) per fusion pressure.
F igure  12b: C o m p o u n d s  A , J , K , M , N .  (See Tables  1 & 3).
M ean  basal per fusion pressure for all com pou nds  tested 9 6 ± 2 . 6 m m H g  n =  69.
O —  O C o m p o u n d  A
• ------•  C o m p o u n d
A  —  A  C o m p o u n d  
▲ —  ▲ C o m p o u n d  
□ ----- □  C o m p o u n d













0 . 5 5 . 0 50 1 0 0
nmole s
62
1.2 Effect of verapamil on constrictor and dilator responses to Compound G.
The effect o f  verapamil on responses to compound G was investigated in order to 
investigate whether the coronary constrictor or the coronary dilator activity o f  
com pound G is mediated via an effect on L-type calcium channels.
C om pound G was used for these experiments as it produced the greatest and most 
consistent degree of  coronary constriction, as well as a coronary dilator response. It 
can be seen from Figure 13 that the constrictor component of  the response to 
com pound G is almost completely lost in the presence o f  lOOnM verapamil. This is 
shown also in the graph in Figure 14. The coronary dilator component was also 
significantly reduced ( p < 0 .0 5 ) ,  at the optimal dose (30nmoles) it was reduced from 
42 +  8 .8 % to 4.5 ± 2 .6 % .  However, verapamil itself significantly reduced the basal 
perfusion pressure; 9 5 + 5 .6 m m H g  in the absence of  verapamil and 5 3 ± 2 .4 m m H g  in 
the presence o f  verapamil (lOOnM; p < 0 .0 5 ) .
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Figure 13
Trace showing the effect of lOOnM verapamil on the coronary dilator and constrictor 
responses to bolus doses of  Compound G in the isolated, perfused rat heart.
Figure 14
The effect o f  lOOnM verapamil on coronary constrictor responses to bolus doses of 
Compound G in the isolated, perfused rat heart. Data expressed as mmHg increase in 
perfusion pressure.
Basal perfusion pressure: Control 95 + 5 .6 m m H g  n = 6 ; In presence of lOOnM 
verapamil 5 3 ± 2 .4 m m H g  n - 4 .  * p < 0 .0 5 ,  Student's unpaired t-test.
Dose-response curve to Compound G:
—■—Control n=6 
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1.3.1 Effect of llOm M  K + on coronary dilator responses to PIPi, verapamil, 
papaverine, salbutamol, nicardipine and lemakalim.
These experiments were performed to investigate a possible action o f  P IP i  on 
potassium channels. A concentration o f  l lO m M  K +  outside the coronary smooth 
muscle cells produces a depolarisation o f  the smooth muscle and hence coronary 
constriction.
According to the Nernst equation (At body temperature (37°C)), and assuming the 
m em brane to be permeable only to potassium
E m =  61 . log io  [Cone, o f  K +  outside the cell]
[Cone, o f  K +  inside the cell]
Em being the potential difference across the sarcolemma.
Therefore, prior to the addition o f  high potassium ie. in the presence o f  3 .2 mM K"1", 
according to the Nernst equation: -
Em =  61 . lo g i0 [T 2 ]  =  -lOOmV
[140]
W hereas on perfusion o f  l lO m M  K +  solution:-
Em =  61 . lo g io  [ 11Q3 =  "6mV
[140]
However, in the presence o f  3 .2m M  K +  the potential across the sarcolemma is likely 
to be much less negative than the m embrane potential produced by the Nernst 
equation, as at this concentration physiologically, other factors such as ion pumps can 
affect the m em brane potential. A concentration as low as 3 .2m M . K +  in coronary
smooth muscle is likely to slightly depolarise the smooth muscle; because in these
experiments, switching to 3 .2m M  K “*" from an original 5 .9m M  K +  perfusate
produced an increase in coronary perfusion pressure (see Section 1.1, Results). This
is possibly due to a low concentration o f  K~*~ ions on the outer sarcolemmal surface
producing an inhibition o f  N a ^ - K ^ - A T P a s e ,  thus producing an increase in
intracellular sodium. This could cause a secondary increase in intracellular calcium
2 +
through an increase in calcium influx through the N a + -Ca exchanger and 
subsequent calcium-induced calcium release from the sarcoplasmic reticulum. Thus, 
the Nernst equation cannot give an accurate estimate o f  the membrane potential at this 
low concentration o f  potassium. However, from the Nernst equation, it is clear that in 
the presence o f  l lO m M  K +  , there is a very high degree o f  depolarisation o f  the 
m em brane potential, to -6 mV. This has been shown to impair the action of 
vasodilators which act via activation o f  potassium channels, as a high concentration of 
potassium outside the cells will reduce the driving force o f  potassium ions out of the 
cell following potassium channel activation (Hamilton et a l ., 1986; W eir and Weston 
1988). The effect o f  1 lOmM K +  on the actions o f  other coronary dilators, known to 
act either independently o f  potassium channels (verapamil, papaverine, nicardipine) or 
via the activation o f  potassium channels (lemakalim and possibly salbutamol), were 
compared with the effect o f  1 lOmM K~*~ on the coronary dilator effect of P IP i. The 
dose used for each coronary dilator was chosen to produce an approximately 
equivalent degree o f  coronary dilation.
Figure 15 is a representative trace showing the effect o f  l lO m M  K +  on the coronary 
dilator responses to verapamil and P IP i .  Following perfusion o f  1 lOmM K +  , a 
contracture developed in the myocardium  together with an increase in perfusion 
pressure (Before;- 108 +  3 .2m m H g, in presence o f  l lO m M  K +  :- 1 5 4 + 4 .9m mHg, 
n = 5 0 ) ,  however there was no significant difference in the response to a submaximal 
dose o f  verapamil (1 nmole), before or during perfusion with 1 lOmM K +  . Prior to 
1 lOmM K +  perfusion;- 43 +  1 .5m mHg; in presence o f  1 lOmM K +  :- 3 7 + 2 .3 mmHg 
dilation, n = 5 0 .  The 1 nmole verapamil dose was used to gauge responses to other
vasodilators shown in Figure 16. Each coronary dilator dose was repeated to ensure 
reproducibility prior to and following the perfusion of l lO m M  K +  , indicated by the 
two bars on the graph before and after treatment. These were administered alternately 
with lnm o le  o f  the calcium antagonist verapamil, used as an internal control. It can 
be seen from  Figure 16 that P IP i (0.5nmoles) produced a coronary dilator response 
that was reproducible in the same preparation and approximately equal to a lnm ole  
verapamil response in terms o f  degree o f  dilation. The P IP i  response was virtually 
abolished following perfusion with llO m M  K +  ( p < 0 .0 5 ;  Figure 16). Coronary 
dilator responses produced by lOnmoles o f  the channel activator lemakalim
were completely abolished in the presence of  110mm K +  . Papaverine (30nmoles) and 
the dihydropyridine nicardipine (0.5nmoles) responses were not significantly altered in 
the presence o f  l lO m M  K +  (NB. The 0.5nm ole nicardipine dose was not repeated 
prior to administration o f  l lO m M  K +  , due to the long duration of  the coronary dilator 
response). Salbutamol responses were smaller ie. not equivalent to lnm ole  verapamil, 
but w ere  significantly reduced in the presence of l lO m M  K +  .
In time-m atched control preparations (Figure 17), verapamil responses were not 
significantly different before or after 15 minutes control perfusion (3 5 ± 3 .5 m m H g  
initially, 3 2 + 5 .0 m m H g  after time-matched perfusion period, n =  18). P IP i and 
lemakalim responses were also not significantly different following 15 minutes time- 
matched perfusion. However, there was a significant ( p < 0 .0 5 )  tachyphylaxis to the 
salbutamol response.
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Fig ure  15
T r a c e  s h o w i n g  the ef fect  1 lOmM po ta ss i um on  the c or onar y  d i la tor ,  deve lo ped  tension 



































Fi g u re  16
Effec t  o f  1 lOmM potassium on the coronary dilator responses to bolus doses o f  PI P i .  
l e m aka l im ,  papaver ine ,  salbutamol and nicardipine in the isolated perfused rat heart.  
Each  dose  was repeated to ensure reproducibil i ty,  except  in the case o f  nicardipine.  
Data  expressed  as % lnmole  verapamil response.
Basal  per fus ion  pressure:  3 .2mM K +  107 +  3 .2 m m H g ;  7 '  K +  154 +  4 . 9mmHg
n =  18. * p < 0 . 0 5  S tudent 's  paired t-test.
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T i m e - m a tc h e d  control  curves to F igure 16 s h o w in g  the effect o f  repeated boluses of 
the co ro na ry  di la tors P I P i ,  salbutamol and lemakal im  fol lowing 20  minutes time- 
matched  per fusion .  Data expressed as % l n m o l e  verapami l  response.
Basal per fusion pressure:  3 .2 m M  K “*“ 93 +  8. I m m H g ;  Fol lowing  20 minutes perfusion 
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1.3.2 Effect of 20mM K + on coronary dilator responses to PIPi and verapamil.
The effect o f  20m M  K +  potassium on coronary dilator response to PIP i was also 
investigated. This concentration of potassium would produce a depolarisation of the 
cell, but to a lesser extent than the presence o f  1 lOmM K +  .
Fitting the Nernst equation (see above)
Em =  61 -log 10 [20] =  -51mV
f l4 0 j
Therefore  the presence o f  20mM K +  would produce a depolarisation to -51mV, and 
potassium efflux would still occur following potassium channel activation. A 
concentration o f  more than approximately 40mM  K ”*“ outside the cell is required to 
prevent the vasodilator action o f  potassium channel activators (Hamilton et al., 1986; 
Chappell et a l.,  1990).
Following perfusion of 20m M  K +  , a sustained contracture developed in the 
m yocardium  in a similar way to that shown in llO m M  K “*" experiments, 
accom panied by an increase in perfusion pressure; from 9 8 ± 4 .6 m m H g  prior to the 
addition o f  20m M  K +  , to 1 5 6± 6 .1m m H g in the presence of 20mM K +  ; but again 
there was no significant difference in the response to verapamil before the addition of 
20m M  K~*“ (4 2 ± 5 .6 m m H g , n = 4 )  or in the presence of 20mM  (3 3 ± 3 .5 m m H g , 
n = 4 ) .  In this case the coronary dilator responses to P IP i  were reduced significantly 
( p < 0 .0 5 ) ,  but not to the same extent as for the experiments using llOmM  K +  , the 
responses being reduced by only 43 +  9 .7% , n = 4  in the presence of 20mM  K +  , and 
not abolished as shown in llO m M  K +  experiments (Figure 18).
Fi gu re  18
Effec t  o f  2 0 m M  K +  on  the c o ro n a ry  d i la tor  responses  to f : 1. :  doses  o f  P I P i  in the 
isolated per fu sed  rat heart .  Each dose  was  repea ted to ensure  reproducib i l i ty .  Data  
expr es se d  as % l n m o l e  ve rapami l  response .
Basal p e r fus io n  pres sure :  3 . 2 m M  K +  113 +  7 . 5 m m H g ;  2 0 m M  K +  1 5 3 + 5 . 2 m m H g  
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1.4 Effect of tetraethylammonium chloride (TEA) on coronary dilator responses 
to PI Pi.
In order to investigate further the effect of PI  Pi on K +  channels, the effect o f  the 
non-specific K +  channel blocker TEA was investigated.
T E A  at a concentration of lOmM produced an increase in perfusion pressure, from 
8 1 ± 7 .9 m m H g  in the absence o f  TEA, to 112 ± 1 5 .8 m m H g  in the presence o f  lOmM 
T E A  (n =  6 ). The same concentration o f  TEA produced a fall in heart rate o f  
5 7 ± 1 4 b p m  from a basal heart rate o f  2 8 6 ± 6 b p m , n =  6 . There was no significant 
effect on developed tension. It can be seen from Figure 19 that lOmM TEA  did not 
abolish coronary dilator responses to PI  Pi. However there was a significant 
depression o f  the coronary dilator responses to P IP i ,  although the dose o f  P IP i  
producing the maximum dilator response remained the same. The coronary dilator 
response to 1 nmole verapamil, used as an internal control, was not significantly 
altered before the addition o f  TEA: 35 +  3.3% relaxation from basal perfusion 
pressure, or in the presence o f  TEA: 3 7 + 5 .0 %  relaxation, n =  6 .
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Figure  19
Dose- response  curve  showing coronary  dilator responses to P IPi  in the absence  and 
presence lOmM te t rae thy lammonium chlor ide  (TEA) .  Data expressed as % relaxation 
f rom basal per fusion pressure.
Basal (elevated) per fusion pressure:  Control  114 +  3.1 m m H g  n = 4 ;  lOmM T E A  
112 +  16 m m H g  n =  6. * p < 0 . 0 5  S tudent ' s  unpaired t-test.
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1.5 Effect of PIPi on the perfusion pressure, developed tension and heart rate 
responses to BAY K 8644, noradrenaline, PGF2 a , methoxamine and caffeine .
These experiments were performed in order to investigate the interaction o f  PIP i with 
various vasoconstrictor compounds, in order to further elucidate the 
mechanism(s) o f  coronary dilation o f  P IP i.
1.5.1 Effect o f PIPi on basal parameters.
At a concentration o f  InM , P IP i  had no effect on any o f  the basal parameters 
measured. Increasing the concentration o f  P IP i  to lOnM had no effect on basal 
developed tension and heart rate, but coronary dilation did occur, as indicated by a fall 
in perfusion pressure o f  19 ± 2 .8 m m H g  to a mean value o f  6 8 + 4 .  Im m H g (n = 2 4 ) .
In experiments where the concentration o f  P IP i  was increased to lOOnM, P IP i  caused 
an initial fall in perfusion pressure o f  1 2 + 1 .3 m m H g  (n = 9 ) ,  which was not associated 
with any change in developed tension or heart rate. Increasing the concentration o f  
P IP i  to 1/xM did not produce a further fall in perfusion pressure. This concentration 
also had no effect on developed tension or heart rate (n = 5 ) .
1.5.2 Effect of PIPi on responses to BAY K 8644.
In these experiments, the basal perfusion pressure, heart rate and developed tension 
were 6 9 ± 8 .2 m m H g , 2 7 1 + 2 3 b p m , and 6 .9 ± 0 .7 g  respectively.
Bolus doses o f  BAY K 8644 (KMOOpmol.) produced well defined, transient, dose- 
dependent increases in perfusion pressure with small, inconsistent increases in
developed tension. Heart rate was not affected. Doses above lOOpmol were not 
used in control curves as perfusion pressures would have exceeded 200mmHg.
P IP i  (lOnM - 1/zM) produced a concentration dependent inhibition o f  the coronary 
constrictor action o f  BAY K 8644 (Figures. 20 & 21). There was no significant shift 
o f  the dose-response curve in time-matched control experiments (data not shown).
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Figure 20
T r a c e  s h o w i n g  the e ffects  o f  P I P i  on the pe r fus ion  pressure  (PP) .  deve lo ped  tension 
( D T )  and  hea r t  rate (H R)  responses  to bo lus  doses o f  BAY K 8644  in the isolated 
pe r fu se d  rat  hear t .
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I Effect o f  PI Pi on the coronary cons tr ictor  responses to bolus doses of  BAY K 8644 in 
the isolated per fused rat heart.  Data expressed  as m m H g  increase in per fusion 
pressure.
Basal perfusion  pressure: Control  6 9 ± 8 . 2 m m H g ;  lOnM P IP i  5 7 ± 1 . 4 m m H g ;  lOOnM 
P I P i  5 4 ± 2 . 0 m m H g ;  \(jlM  P IP i  6 1 ± 4 . 3 m m H g  n =  5, *1 p < 0 . 0 5  compared  with 
Cont ro l ,  *2 p < 0 . 0 5  compared  with lOnM P I P i ,  *3 p < 0 . 0 5  compared  with lOOnM 
P I P i ,  2 way A N O V A .
D o s e - r e s p o n s e  cu rve  to  BAYK8644 
•  —  •  CONTROL
A A lOnM P 1 Pi 3 i n c l u d e d  in
■  B  100nW PI Pi | p e r f u s a t e
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100 300
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1.5.3 Effect of PIPi on responses to noradrenaline.
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The initial aim  o f these experim ents was to investigate the effect o f P IP i on the 
coronary  constrictor action o f  noradrenaline. H ow ever, it can be seen from  Figure 22 
that noradrenaline produced only a very small degree o f  coronary  constriction, 
preceding a large coronary  dilator response at higher doses. This was accom panied by 
dose-related  positive inotropic and chronotropic effects (F igure  22). T he positive 
inotropic effect was biphasic, consisting o f an initial, transient inotropic effect, 
follow ed by a later, m ore prolonged inotropic response. Follow ing perfusion with 
P IP i (In M  and lOnM) the second phase o f the positive inotropic response to 
noradrenaline was significantly depressed in a concentration dependent m anner (Figure 
22 & 23). In contrast, the chronotropic action o f noradrenaline was not affected by 
P IP i (F igure  22 & 24). A t lOnM, P IP i tended to reduce the coronary dilator action 
o f noradrenaline, but this effect was not significant (F igure  25).
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F ig u re  22
T r a c e  s h o w i n g  the e f fec t  o f  P I P i  on  pe r fus ion  pressure ,  deve loped  tension  and  hear t  


















Effect  o f  P I P i  and atenolol on the positive inotropic response to noradrena line  in the 
isolated,  per fused  rat heart. Data expressed as a % o f  the basal deve loped tension. 
Basal deve lope d  tension: T ime matched control 5 .4  +  0 . 4g  n =  9; I nM  P I P i  4 . 2 + 0 . 7 g  
n =  6; lOnM P I P i  5 . 2 ± 0 . 5 g  n =  6; 1/lcM Atenolol 5 . 6 ±  1. lg  n = 5 ,  * p < 0 . 0 5 ,  
c o m p ared  wi th  t ime-matched controls,  1 way A N O V A .
D o s e - r e s p o n s e  curve to noradrenal ine.
O  O  T i m e -m a tc h e d  control  n = 9
included in pe r fu sa t e□  □  10nM PI Pi n=6
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Effect  o f  P IP i  and alenolol  on the posit ive chronotropic  response to noradrena line  in 
the isolated, perfused rat heart .  Data expressed as bpm above  basal heart  rale.
Basal heart  rate: T im e  matched control  2 7 7 ± 1 0 b p m  n =  9; I nM  P IP i  2 9 7 ± I 2 b p m  
n =  6; lOnM P IP i  2 6 0 ± 1 9 b p m  n = 6 ;  \ fxM Atenolol 2 7 7 ± 4 b p m  n = 5 ,  * p < 0 . 0 5 ,  
compared  with t ime-matched controls ,  1 way A N O V A .
Dose—response  curve to noradrenal ine
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F ig u re  25
Effect  of P I P i  and atenolol  on the co ronary  di lator  responses  to noradrena l ine  in the 
isolated per fused rat heart .  Data expressed as m m H g  decrease  in per fusion pressure.  
Basal pe r fus ion  pressures:  T im e  matched control  8 7 ± 8 . 0 m m H g  n =  9; lOnM P I P i  
9 0 ± 1 5 m m H g  n =  6; 1/zM Atenolol  102 +  8 . OmmHg n = 5 ,  * p < 0 . 0 5 ,  com par ed  with 
t ime  m a tched  controls ,  one way A N O V A .
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1.5.4 Effect o f atenolol on responses to noradrenaline.
In o rder to investigate why P IP i had a selective effect on the inotropic and not the 
chronotropic  effect o f  noradrenaline, the effects o f P IP i were com pared to those o f the 
B j-adrenoceptor antagonist atenolol. For exam ple the lack o f any effect on heart rate 
may be due to a poor perfusion o f the SA node in this preparation. If adequate 
perfusion  o f  the SA node were present, the B^-adrenoceptor antagonist atenolol should 
antagonise both the positive inotropic and the positive chronotropic effect o f 
noradrenaline.
In contrast to P IP i, atenolol at 1/zM significantly reduced both the inotropic and 
chronotropic actions o f  noradrenaline (Figures 23 & 24). A t the concentration used, 
atenolol also significantly  reduced the coronary dilator action o f noradrenaline. This 
inhibition was greater than that shown with lOnM P IP i (F igure 25).
1.5.5 Effect o f palmitoyl carnitine on responses to noradrenaline.
In view  o f the results obtained with P IP i, further experim ents were carried out in 
o rder to investigate w hether the parent com pound, palm itoyl carnitine, was able to 
produce the sam e effect.
Palm itoyl carn itine at lOnM produced an increase in perfusion pressure from 
8 5 ± 1 1 .5 m m H g  to 115± 16 .5m m H g (n =  6 ). It produced no significant effect on 
developed tension or heart rate. Palm itoyl carnitine at lOnM had no significant effect 
on the positive inotropic responses to noradrenaline, m easured as a % increase from 
basal developed tension (Figure 26).
The positive chronotropic  responses were also not significantly affected by palm itoyl 
carnitine; in tim e m atched control curves 3nm oles noradrenaline produced an increase
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in heart rate o f  102± 14bpm , n =  9; whereas in the presence o f lOnM palm itoyl 
carnitine the increase was 9 2 ± 1 4 b p m , n —5. The coronary dilator response to 
3nm oles noradrenaline was also not significantly affected; at 3nm oles a coronary 
dilator response o f  2 3 ± 4 .2 m m H g , n = 9 , was produced in tim e matched control 
curves, and 2 2 ± 6 .1 m m H g , n = 6 , in the presence o f  lOnM palm itoyl carnitine.
1 .5 .6  Effect o f polmyxin B on responses to noradrenaline.
T he fact that P IP i inhibited the positive inotropic effect o f noradrenaline, while the 
parent com pound palm itoyl carnitine did not may be related to the fact that P IP i is a 
positively charged am phiphile, while palm itoyl carnitine is a zwitterion. In order to 
investigate this possibility further, the effect o f  another cationic am phiphile, 
po lym yxin B, on noradrenaline responses was com pared with the actions o f P IP i and 
palm itoyl carnitine. Polym yxin B at 1/zM slightly increased perfusion pressure, 
7 9 ± 1 3 .9 m m H g  prior to the addition o f polym yxin B; 102+ 17 .2m m H g in the 
presence o f polym yxin B, but this increase was not significant. Basal heart rate and 
developed tension w ere also not significantly affected. A concentration o f 1/xM 
polym yxin B also had no significant effect on the positive inotropic response to 
noradrenaline (F igure 26). In addition, positive chronotropic and coronary dilator 
responses induced by noradrenaline were not affected. At a submaximal dose o f 
noradrenaline (3nm oles) the increase in heart rate was 102+ 14bpm , n =  9, in the 
absence and 8 9 + 2 7 b p m , n = 4 , in the presence o f IfxM polym yxin B. The same dose 
(3nm oles) o f  noradrenaline produced a coronary  dilation o f 23 +  4 .2m m H g, n =  9, in 
the absence and 2 8 ± 9 .6 m m H g , n = 4 , in the presence o f 1/zM polym yxin B.
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Fi gu re  26
T h e  e f fec t  o f  palmi toyl  carni t ine and p o ly m yx in  B on the posit ive inotropic response  to 
no ra d re na l in e  in the isolated per fused  rat heart .  Data expressed as % o f  the basal 
d e ve loped  tension.
Basal deve lop ed  tension:  T ime  matched  control  5 . 4 ± 0 . 4 g  n =  9; lOnM palmitoyl  
ca rn i t ine  3 . 6 ± 0 . 3 g  n - 6 ;  po l ymyxin  B 4 . 6 ± 0 . 4 g  n = 4 ,  * p < 0 . 0 5 ,  co mp ared  with 
t im e-m a tc hed  cont rols ,  one  way A N O V A .
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1.5.7 Effect of PIPi on responses to PGF2a .
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In o rder to investigate whether P IP i could suppress the responses to vasoconstrictors 
other than BAY K 8644, the effect o f P IP i on PG F 2 a , show n to be a potent 
constric tor in coronary  smooth muscle (N akajim a & U eda 1990; Balwierczak 1991) 
was investigated.
PG F 2 a  produced a very sm all, variable coronary constric to r effect. H ow ever, it also 
produced a m onophasic, dose-related positive inotropic effect with no concom itant 
effect on heart rate (F igure 27). A concentration o f  lOnM  P IP i significantly reduced 
the positive inotropic effect o f PG F2a  (F igure 28). C oronary  constrictor responses 
w ere not large enough to be m easured accurately.
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F ig u r e  27
T r a c e  s h o w i n g  the e ffec t  o f  P I P i  on the dev e lo p e d  tension (DT) ,  hear t  rate (HR)  and 




Th e  e ffec t  o f  P IP i  on the positive inotropic responses to P G F 2 a  in the isolated 
perfused rat heart ,  expressed as % of  the basal deve loped tension.
Basal deve loped tension: T ime-matched  control 6 . 8 + 0 . 7 g  n = 4 ;  lOnM PIPi  7 . 4 ± 0 . 8 g  
n = 4 ,  * p < 0 . 0 5  Student 's  unpaired t-test.
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1.5.8 Effect of PIPi on responses to methoxamine.
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In o rder to investigate w hether the ability o f  P IP i to suppress agonist-induced positive 
inotropic responses could be applied to other agonists, as well as noradrenaline and 
PG F2 a , the effect o f  P IP i on responses to the a-adrenoceptor agonist m ethoxam ine 
was investigated.
Positive inotropic responses to m ethoxam ine were found to be subject to tachyphylaxis 
on repeating the dose-response curve. Therefore in these experim ents, 1st dose- 
response curves w ere carried out in the presence o f  P IP i for test experim ents, and 
control curves in separate preparations. M ethoxam ine produced a dose-related 
positive inotropic effect which was m onophasic with no significant effect on heart rate, 
and a variable effect on perfusion pressure.
At lOnM , P IP i significantly reduced the m ethoxam ine-induced positive inotropic 
response, as show n in F igure 29. Coronary constrictor responses were not m easured 
















Fi gu re  29
Effect  o f  P IP i  on the positive inotropic response to me tho xamin e  in the isolated 
per fused  rat heart.  Data expressed as % o f  the basal developed  tension. First  dose- 
respons e  curves shown, in the presence or absence of  P IP i .
Basal deve loped  tension: T ime-matched  control 6. l ± 0 . 7 g  n =  9; lOnM PIP i  7.1 +  1.3g 
n =  5,  * p < 0 . 0 5  S tudent ' s  unpaired t-test.
Dose—response  curve to me t hox ami ne  
• —  •  Control n = 9
O  o  *n the  p r esence  of 
1 OnM P 1 Pi n = 5
1 50  t
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1.5.9 Effect o f PIPi on responses to caffeine.
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T he action o f P IP i to suppress agonist-induced positive inotropic responses could 
involve an inhibition o f calcium  influx or calcium  release from the sarcoplasm ic 
reticulum . H ow ever, the inhibition o f BAY K 8644-induced positive inotropic 
responses appears to suggest an inhibition o f  calcium  influx thorough L-type calcium 
channels in vascular sm ooth muscle. In order to investigate whether P IP i could 
influence calcium  release from  the sarcoplasm ic reticulum , the effect o f P IP i on 
caffeine responses was investigated.
F igure 30 shows the effect o f caffeine on the three param eters m easured. Caffeine 
(0.3-30/zm oles) produced a sm all, transient coronary constrictor response, associated 
in som e cases with a  transient positive inotropic effect with a duration o f  only 2-3 
beats, follow ed by a longer lasting coronary  dilator effect. Heart rate was unaffected. 
P IP i at both lOnM and lOOnM had no significant effect on the coronary constrictor 
responses to caffeine (F igure 31). The coronary  dilator response was significantly 
( p < 0 .0 5 )  attenuated in the presence o f 10 o r lOOnM P IP i. In the absence o f P IP i, a 
fall o f  1 8 .0 + 5 .8m m H g perfusion pressure was produced with 30^m oles caffeine, in 
the presence o f lOnM P IP i this was reduced to 3 .8 ± 1 .8 m m H g , and in the presence of 
lOOnM P IP i the coronary dilator response was abolished.




Trace showing the effect o f P IP i on coronary perfusion pressure, developed tension 























Effect o f  P I P i  on  the coronary  constr ictor  responses to bolus doses o f  caf feine  in the 
isolated, per fused  rat  heart .  Data expressed as m m H g  increase f rom basal per fusion 
pressure.
Basal per fusion pressure:  Control  7 1 + 7 . 4 m m H g ,  lOnM P I P i  6 9 ± 6 . 4 m m H g ,  lOOnM 
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1.6 Effect of noradrenaline following washout o f PIPi (reversibility experiments).
T hese experim ents were carried out to investigate the reversibility o f the action of 
P IP i, to suppress the positive inotropic response to noradrenaline.
It can be seen from  Figure 32 that the inhibitory effect o f  lOnM P IP i on the positive 
inotropic response to 1 nm ole noradrenaline was com pletely reversed follow ing 40 
m inutes w ashout o f  P IP i.
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Figure 32
Effect of a 1 nmole bolus of noradrenaline on developed tension before perfusion of 
P IP i, in the presence o f PIP i and following 40 minutes washout of PIPi. Data 
expressed as % of the basal developed tension prior to each 1 nmole bolus o f 
noradrenaline administered.
Basal developed tension: Prior to 1st 1 nmole dose noradrenaline (control) 8 .4 ± 0 .7 g ;
In presence of lOnM PIPi 8 .5± 0 .8g ; following 40 minutes washout (w/o) PIPi 
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1.7 Effect of increasing the heart rate by electrical pacing in the isolated perfused 
heart on developed tension and perfusion pressure.
In o rder to investigate the influence o f an increase in heart rate on the other param eters 
m easured, to help explain the responses obtained in response to noradrenaline in 
previous experim ents, hearts were paced at intervals at increasing frequencies.
F igure  33 is a representative trace showing the effect o f  heart rate on developed 
tension and perfusion  pressure. There was a frequency-dependent coronary dilator 
effect which increased as the stim ulation frequency was increased. There was also a 
frequency dependent immediate positive inotropic effect, followed by a delayed, 
frequency dependent depression o f contractility  in response to an increase in heart rate. 
This pattern  was observed in each experim ent perform ed (n =  6 ).
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Figure 33
Trace showing the effects o f electrical pacing for 30 seconds on developed tension and 
perfusion pressure in the isolated, perfused rat heart.
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1.8.1 Effect of sequentially lowering the sodium concentration in the perfusate on 
developed tension.
Experim ents using low sodium  perfusion w ere perform ed in order to investigate the 
effect o f  P I Pi on positive inotropic and coronary constrictor responses elicited by 
m odulation o f  N a + -C a2 +  exchange.
The trace in F igure 34 shows that sequentially low ering the concentration o f sodium  in 
the perfusate , from  118 to 89 to 59 to 44m M  NaCl, produced a sequential increase in 
developed tension, a depression o f heart rate and com plex effects on perfusion 
pressure. T he effect o f sodium  concentration on developed tension is show n in F igure
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Figure 34
Representative trace showing the effect o f progressively lowering the sodium chloride 
concentration in the perfusate on developed tension, perfusion pressure and heart rate 
in the isolated perfused rat heart.






















Fig u re  35
Effect of progressively lowering the sodium chloride concentration in the perfusate on 
developed tension in the isolated, perfused rat heart. Data expressed as % o f the basal 
developed tension.













1.8.2 Effect of PIPi on the actions of a low sodium (59mM NaCl) perfusate on 
developed tension, heart rate and perfusion pressure.
A concentration o f 59m M  NaCl was used, as this was found to produce a submaximal 
increase in developed tension in the previous experim ent. Perfusing hearts with the 
low sodium  solution for 5 minutes at 20 m inute intervals induced a positive inotropic 
response, bradycardia and a com plex effect on perfusion pressure consisting o f a smail 
coronary  constriction follow ed by a coronary dilator com ponent (Figure 36). Third 
low sodium  perfusion responses are quoted, because in control preparations these 
responses w ere found to be not significantly different to second responses. In control 
hearts the third low sodium  perfusion period produced a developed tension o f 
1 6 3 + 1 2 .7 %  o f its resting value ( n = 6) while in the presence o f P I Pi (lOnM ) 
developed tension was 1 6 4+ 7 .2%  o f the resting value ( n = 8) ie. not significantly 
d ifferen t from  the control response. The decrease in heart rate induced by third low 
sodium  perfusion periods in control and P IP i (lOnM ) treated hearts were 47 +  9 and 
59 +  7 bpm  respectively ( n = 6 -8), these decreases were not significantly different.
Basal heart rates in these control and P IP i treated hearts were 2 8 6 + 1 0  and 294 +  13 
bpm  respectively (n =  6 -8). C oronary perfusion pressure changes induced by the third 
low sodium  perfusion period in control hearts consisted o f an initial coronary 
constriction which increased 14+ 0 .4m m H g above the basal perfusion pressure of 
76 +  3 .8m m H g (n =  6 ). This was followed by a fall in pressure which reached a value 
o f l l+ 2 .2 m m H g  below  the basal perfusion pressure, ie. from its peak value, 
perfusion pressure fell by an average o f 25m m H g. In the presence o f P IP i (lOnM ) 
basal perfusion pressure was 6 5 + 4 .6 m m H g  (n =  8) and the equivalent increase in 
perfusion pressure due to low sodium  perfusion was 13± 2 .7m m H g (n =  8 ), an effect 
which was not significantly different from the control response. H ow ever the 
coronary  dilator com ponent o f the response to low sodium  was significantly (p <  0.05) 
attenuated in the P IP i treated hearts. In the presence o f P IP i the perfusion pressure 
fell O .l+ O .lm m H g  ( n = 8 ) below  the basal value com pared with l l + 2 .2 mmHg ( n = 6 ) 
in the control experim ents.
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Fi gu re  36
Trace showing the effect of PIP i on the developed tension (DT), heart rate (HR) and 
perfusion pressure (PP) responses to low sodium (59mM) perfusion in the isolated 





















1.9. The effect of PIPi or palmitoyl carnitine on the effects of 3x 20 minutes zero 
flow global ischaemia / reperfusion in the isolated heart.
T he ability  o f  P IP i to inhibit the actions o f m ediators such as catecholam ines and 
prostaglandins which are know n to be released following ischaem ia, and which may 
con tribu te  to ischaem ically-induced dam age (Cerem uzynski et. a l., 1969; B erger et 
a l., 1976), raises the possibility  that P IP i could be protective under conditions o f 
ischaem ia / reperfusion. In addition, both potassium  channel openers (G rover et a l., 
1989; G ross &  A ucham pach, 1992) and calcium  antagonists (W atts et a l., 1986) have 
been show n to produce protective effects in global ischaem ia / reperfusion m odels, and 
P IP i has show n characteristics in com m on with both these classes o f com pound. 
T herefo re  these experim ents were perform ed in order to investigate w hether P IP i 
could m odify the ischaem ic contracture o r depression o f developed tension produced 
by zero  flow  global ischaem ia in the isolated rat heart. The actions o f P IP i were 
com pared with the actions o f the parent com pound palm itoyl carnitine.
1.9.1 The effect of 3x 20 minutes global zero flow ischaemia / reperfusion on 
developed tension, heart rate and perfusion pressure in the isolated rat heart.
F igure 37a is a representative trace show ing the effect o f 20 minutes zero flow global 
ischaem ia / reperfusion, repeated three tim es on perfusion pressure, heart rate and 
developed tension in the isolated rat heart. D uring the first 20 m inute period o f 
ischaem ia, the developed tension dropped o ff  slowly and a small degree o f ischaemic 
con tractu re  developed. H eart rate initially increased slightly , possibly due to 
im pairm ent o f  the triggering o f  the rate m eter, but heart rate was lost as the ischaemic 
contracture  developed. On the first period o f  reperfusion, an im m ediate increase in 
coronary  perfusion pressure was obtained, which was follow ed by a rapid fall in 
perfusion  pressure, and subsequently a gradual coronary constriction developed 
starting  at approxim ately  5 minutes after reperfusion. D eveloped tension was re­
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established on reperfusion but the force o f contraction was reduced com pared to that 
before  ischaem ia. There was no difference in heart rate before or after 20 m inutes 
ischaem ia. In subsequent ischaemic periods, the ischaem ic contracture increased and 
in subsequent periods o f reperfusion, there was a further depression o f developed 
tension and coronary  constriction developed m ore rapidly.
F igures 38 and 39 show  in graphical form  the effect o f  3x 20 minutes ischaem ia / 
reperfusion  on contracture developed during each ischaem ic period and the developed 
tension during each period o f reperfusion respectively.
1.9 .2  The effect o f PIP i on ischaemic contracture, and developed tension and 
perfusion pressure during reperfusion, produced by 3x 20 minutes ischaemia / 
reperfusion in the isolated rat heart.
Figure 37b is a representative trace o f the effect o f  lOOnM P IP i on the effect o f 3x 20 
m inutes ischaem ia / reperfusion in the isolated rat heart. At the lower concentration of 
lOnM , P IP i had no effect on ischaemic contracture or depression o f developed tension 
during reperfusion (F igure 38 & 39). H ow ever, in the presence of lOOnM P IP i, the 
contracture  developed was slightly, but not significantly , suppressed during the first 20 
m inutes ischaem ia. There was no significant effect o f P IP i on subsequent periods of 
ischaem ia (F igure  38). A t neither concentration was there any effect o f P IP i on 
depression o f  developed tension following reperfusion (Figure 39).
At a  concentration  o f  lOOnM, how ever, P IP i significantly (p < 0 .0 5 )  inhibited the 
slow ly developing coronary  constriction produced during each period o f reperfusion 
(F igures. 37 & 40).
106
1.9.3 Effect o f palmitoyl carnitine on ischaemic contracture, and developed 
tension and perfusion pressure during reperfusion, produced by 3x 20 minutes 
ischaemia / reperfusion in the isolated rat heart.
Palmitoyl carnitine at a concentration o f  lOOnM had no significant effect on ischaemic 
contracture, or developed tension during reperfusion in these experiments (Figure 38 
& 39). The slowly developing coronary constriction, commencing after approximately 
5 minutes reperfusion, was also not significantly affected by lOOnM palmitoyl 
carnitine (data not shown).
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F ig u r e  37a
T ra c e  sh o w in g  the e ffec t o f  3x 20 m inutes zero  flow global ischaemia / reperfusion  on 
d ev e lo p ed  tension , heart  rate and perfus ion  pressure  in the isolated perused  rat heart.
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Figure  37b
T ra c e  sh o w in g  the e ffec t o f  3x 20 m inutes zero  flow global ischaem ia  / reperfus ion  on 
deve loped  tens ion , heart rate and perfusion  pressure  in the isolated perfused  rat heart 
in the p resen ce  o f  lOOnM P IP i .
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F igure  38
T h e  e f fec t  o f  P I P i  and palmitoyl carn itine  (PC) on the three per iods  o f  ischaem ic 
c o n tra c tu re  d ev e lo p ed  during  3x 20 m inutes zero  flow global ischaem ia  in the isolated, 
pe rfused  rat hear t .  Data expressed as basal (diastolic) tension (g).
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F i g u r e  39
T h e  e f fec t  o f  P I P i  and palmitoyl carn itine  (PC) on the 3x 20  m inute  periods o f  
re p e r fu s io n ,  fo llow ing  20  minutes zero flow  global ischaem ia  in the isolated, perfused  
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F igure  40
T h e  effec t  P I P i  and palm itoy l carn itine  on the increase in perfusion  pressure  d u r ing  
rep e rfu s io n  fo llow ing  3x 20  minutes ischaem ia in the isolated perfused  rat heart.  Data 
exp ressed  as m m H g  increase  in perfusion  pressure  ga ined be tw een  5 and 15 m inutes  
repe rfus ion .
Basal p e rfu s ion  pressure :  Contro l 8 0 ± 5 .8 m m H g ;  lOnM P IP i  77 +  9 .2 m m IIg ;  lOOnM 
P I P i  5 0 ± 3 . 4 m m H g ;  9 5 ± l l m m H g ,  n - 5  for each, * p < 0 . 0 5  com pared  with con tro l 
increases , 1 w ay  A N O V  A.
1 1 Control
EE2 1 OnM PI Pi
100nM P 1 Pi 
E53 100nM Palmitoyl carni t ine  
n =  5 for  e ach .
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2. Isolated, stimulated left atrium of the rat.
2.1 Effect o f PIPi on the increase in developed tension in response to 
noradrenaline in the isolated rat left atrium, stimulated at 0.5Hz.
The use o f  the isolated perfused hearts to investigate the mechanism of  action o f  P IP i  
poses the problem  o f  interaction between vascular and myocardial contractile effects. 
In order to isolate the positive inotropic effects o f  noradrenaline from effects on the 
coronary  vasculature, the effect o f  P IP i  on the positive inotropic action of 
noradrenaline in the isolated left atrium o f  the rat was investigated.
Noradrenaline (lOOnM - 30/xM) added cumulatively to the organ bath produced a 
graded increase in the height o f  the twitch response in response to electrical 
stimulation at 0 .5H z. On washing out and repeating the concentration effect curve at 
20 minute intervals, there was no diminution o f  the responses (Figure 41).
The addition o f  P IP i  at concentrations o f  lOOnM and l^iM had no significant effect on 
the basal twitch height; in time-matched control curves the resting developed tension 
was 53 +  14mg n = 4 ,  in the presence of  lOOnM P IP i  this was 8 3 ± 1 7 m g  n = 4  and in 
the presence o f  1/j.M  P IP i the basal developed tension was 60 +  7. lm g n = 5 .  It can be 
seen from Figures 41 & 42 that P IP i  at concentrations o f  lOOnM and ljxM had no 
significant effect on the noradrenaline-induced increase in developed tension in the 
isolated left atrium (Figures 41 & 42).
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Fig ure  41
T ra c e  sh o w in g  the effect o f  noradrena line  in the isolated left a trium  o f  the rat, 
s t im ula ted  at 0 .5 H z ,  1ms, 50%  above  the threshold vo ltage , both in the absence  and 

















T h e  effec t  o f  P IP i  on the increase in developed tension p roduced  in response to 
noradrena line  in the isolated, s timulated left a trium  o f  the rat. Data expressed as % o f  
the basal developed  tension, third concentra tion  effect curves  show n, in the absence  or 
p resence  o f  PI Pi.
Basal developed  tension: T im e matched control 5 3 ± 1 4 m g  n - 4 ,  lOOnM P IP i  
8 3 ± 1 7 m g  n = 4 ,  1/xM P IP i  6 0 ± 7 . 1 m g  n =  5.
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2.2 Effect of P IP i  on the length of the  tw itch  response in the isolated stim ulated  
left a tr iu m  in the  presence of no rad rena line .
In order to investigate whether PIP i could affect the twitch shortening produced in 
response to noradrenaline, the effect of P IP i on twitch length in the presence of a 
submaximal concentration (3/xM) of noradrenaline in the isolated stimulated left atrium 
was investigated.
Figure 43 shows the effect of PIP i (lOOnM) on the twitch response in the presence of 
3pM noradrenaline in the isolated left atrium, stimulated at 0.5Hz. It can be seen that 
this concentration of PIPi is not able to affect either the twitch height or the twitch 
length. In time-matched control preparations, the length of the twitch response was 
285 +  2 1.8msec after the second and 2 7 2 + 2 1 .3msec, n = 4  after the third application of 
noradrenaline. In test preparations, the second application of noradrenaline (in the 
absence of  PIPi) produced a twitch length of  191+6.6m sec and in the presence of 
lOOnM PIPi (third application) a twitch length of  1 7 8 + 3 .2msec, n = 4 .
Figure 43
Trace of a single twitch (lOOmm/sec) in the isolated left atrium stimulated at 0 .5Hz in 
the presence of noradrenaline, and effect o f  PIP i on this response.
'■ lg Developed Tension
h 100 msec
Og 3/xM Noradrenaline 3/zM Noradrenaline
3. The isolated rat ventricular myocyte preparation.
In view o f  the ability of  PIP i to suppress agonist-induced positive inotropic responses 
in whole hearts, and the lack o f  effect o f  P IP i  on positive inotropic responses in 
isolated atria, these experiments were performed in order to investigate whether PIPi 
could affect calcium fluxes in isolated myocytes. This was achieved by measuring 
intracellular free calcium using fura-2 fluorescence measurements.
During the enzymic digestion o f  the rat heart, perfusion pressure was initially 
5 3 + 2 .4 m m H g  prior to the addition o f  collagenase (n = 3 0 ) .  This increased to a 
m axim um  o f  11 0 + 4 .4 m m H g  on addition o f  20mg collagenase to the recirculating 
solution. Following 20 minutes enzymic digestion, the perfusion pressure fell back to 
a mean o f  3 7 ± 3 .0 m m H g .
Figure  44 shows a typical population o f  rat ventricular myocytes, at x400 
magnification, following the isolation procedure described in the methods section. 
Typically , 60-80% viability was obtained. Cells which were rod-shaped, quiescent 
and showing clear striation were selected for fluorimetric measurements. Figure 45 
shows the fluorescence emitted from one such cell loaded with fura -2 and excited at 
wavelengths o f  340/380nm.
Figure 44
Print o f  rat myocytes, x400 magnification, isolated according to the technique 
described.
Figure 45
Print o f a single myocyte, x400 magnification, loaded with fura-2 and excited at 
wavelengths 340/380 nm.
3.1 Effect of electrical stimulation on the 340/380 fura- 2  signal ratio in a single, 
isolated myocyte.
Shown in Figure 46a is a representative trace of the effect of electrical stimulation at 
1Hz, 1ms duration and at 50% above the threshold voltage, whilst superfusing a 
single isolated cardiac myocyte at 2m l/m in with Im M  C a ^ +  at room temperature, on 
the 1A and 2A signals. These represent the emission at 510nm from excitation 
wavelengths o f  340nm and 380nm respectively. With increasing free calcium within 
the cell, the emission at 510nm from the excitation wavelength of 340nm (1A) 
increases, and from the excitation wavelength of 380nm (2A) the emission at 510nm 
decreases. Therefore, the 340/380 signal ratio is directly proportional to intracellular 
free calcium, and this ratio is represented in Figure 46b, obtained from the 1A and 
2A signals shown in Figure 46a. It can be seen that each electrical stimulus, at 1 
second intervals, produces a several fold increase in the 340/380 fura-2 signal ratio 
which rapidly falls back to the basal ratio prior to the next electrical stimulus. These 
increases indicate calcium transients occurring within the cell, due to membrane 
depolarisation in response to the electrical stimulus. The mean basal 340/380 ratio 
was 0 .7 6 + 0 .0 3 ,  increasing to a maximum of 2 .0 4 + 0 .1 4  following each electrical 
stimulus ( n =  14).
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Figure 46a
The 5lOnm emission signal from a single myocyte alternately excited at 340nm (1A) 
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3 .1 . 1 . 1  Effect of noradrenaline on the 340/380 signal ratio increase in response 
to electrical stimulation at 1 Hz in a single myocyte.
Figure 47a is a representative trace showing the effect of 300nM noradrenaline in the 
superfusate on the 340/380 fura-2 signal ratio in a single myocyte stimulated at 1Hz. 
Following the addition o f  noradrenaline to the superfusate at 60 seconds, there was a 
slowly developing response which reached a maximum after approximately 90 
seconds. It can be seen from Figure 47a that in the presence o f  300nM 
noradrenaline, 150-155 seconds on the time scale, the 340/380 signal ratio increase, 
representing calcium transients, is considerably increased. The 340/380 ratio 
increase was measured from the resting value to the maximum value in response to 
each electrical stimulus; the average o f  5 peaks being measured from 50-55s for 
control levels, and 150-155s for transients in the presence o f  300nM noradrenaline 
for each myocyte. In the presence o f  300nM noradrenaline, the ratio increases in 
response to electrical stimulation were significantly increased; the ratio increase 
being 1 7 4 + 10 .9%  of the ratio increase in the absence o f  noradrenaline (n =  14 
myocytes). The resting 340/380 signal ratio was 0 .7 6 + 0 .0 3  before the addition of 
300nM  noradrenaline and 0 .8 4 + 0 .0 4  in the presence o f  300nM noradrenaline in the 
superfusate, therefore there was no significant change in the resting ratio and thus 
resting calcium concentration. However, the maximum 340/380 signal ratio, and 
thus elevated calcium concentration in response to each stimulus, was significantly 
increased from 2 .0 4 + 0 .1 4  to 3 .1 1 + 0 .4 2 ,  n =  14. It can also be seen from Figure 
47b that the duration o f  the calcium transients is shortened in the presence of 300nM 
noradrenaline. A lower concentration o f  noradrenaline in the perfusate ie. 30 or 
lOOnM was found to have no significant effect on the 340/380 signal ratio increase in 
response to stimulation at 1Hz. Concentrations above 300nM noradrenaline did not 
produce any further increase in the 340/380 signal ratio increase in response to 
electrical stimulation (data not shown). Therefore, no graded response to 




T races  show ing  the fura-2 340 /380  signal ratio increases, represen ting  ca lc ium  
transien ts , in response  to electrical s t im ulation  at 1Hz, in the absence  (50-55seconds) 
and p resence  (150-155seconds)  o f  300nM  noradrenaline in a single m yocy te ,  
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Figure 47b
Trace showing 3 calcium transients from Figure 47a, transients in the presence of 
300nM noradrenaline (NA) superimposed on control transients (time scale for 
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3 .1 .2  Effect of PIPi on basal 340/380 signal ratio increases.
PI Pi had no significant effect on basal 340/380 signal ratio increases in response to 
electrical stimulation at 1Hz. The ratio increase in the presence o f  P IP i  was found to 
be 9 6 + 7 .0 %  o f  that in the absence of P IP i  (n = 5 ) .  However in the presence of 
P IP i ,  there was a consistent increase in the 'noise ' on the trace, ie. the calcium 
transients were found to be less smooth than in the absence o f  P IP i  (see fig. 48).
The duration o f  the calcium transients in the presence o f  P IP i  also appeared shorter 
com pared to control responses, but this was difficult to measure because o f  the 
increased 'no ise '.
3.1 .3  Effect of PIPi and atenolol on the 340/380 signal ratio increase in 
response to noradrenaline.
Figure 48 is a representative trace of the effect o f  noradrenaline on the 340/380 
signal ratio increases in response to electrical stimulation at 1Hz, in the presence of 
lOOnM P IP i .  The presence of lOOnM P IP i  in the superfusate produced a significant 
inhibition o f  the 300nM noradrenaline-induced % increase in the calcium transients, 
measured by 340/380 signal ratio changes (Figure 49). However, the noradrenaline- 
induced shortening o f  the calcium transients did not appear to be affected by PIPi 
(Figure 48b). As with P IP i,  atenolol (1/xM) also significantly inhibited the 
noradrenaline (300nM) induced increases in the calcium transients (Figure 49).
94-
F igure  48a
T ra c e  show ing  the fu ra -2  3 4 0 /3 8 0  signal ratio, representing C az ‘t_ transients  in a 
sing le  m yocy te  superfused  at 2 m l/m in  in response to electrical s t im ula tion  at 1Hz, 
the absence  (50-55s) and  p resence  (150-155s) o f  300nM  noradrenaline, lOOnM PI 
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Figure 48b
Trace showing 3 calcium transients from Figure 48a, transients in the presence of  PIPi 
and noradrenaline (NA) superimposed on transients in the presence of  lOOnM PIPi 
only (time scale for transients in presence o f  both noradrenaline and PIPi =  time 
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F ig u r e  49
T h e  e f fe c t  o f  P I P i  and  atenolo l on  the increase  in the 3 4 0 /3 8 0  signal ra tio  in re sp o n se  
to n o ra d re n a l in e  (N A ).  D ata  expressed  as a  % basal 3 4 0 /3 8 0  signal ra tio  increase .
F o r  each  m y o c y te  the m ean  o f  5 peaks from  5 0 -5 5 seco n d s  in the absence  o f  
n o ra d re n a l in e  (basal) and from  150-155seconds  in the p re se n c e  o f  n o ra d ren a l in e  w ere  
used  to  ca lc u la te  the % increases. * p < 0 . 0 5 ,  co m p a re d  to increases  in the ab se n c e  o f  
P I P i  o r  a te n o lo l ,  1 w ay  A N O V A .
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3 .1 .1 .2  Effect of verapamil on the 340/380 signal ratio increase in response to 
electrical stimulation at 1Hz.
A concentration o f  10/xM verapamil was required to completely inhibit the Ca^ +  
transients (340/380 signal ratio) +
produced in response to 1Hz electrical stimulation (data not shown). Lower 
concentrations o f  verapamil had no significant effect on the calcium transients 
produced in response to electrical stimulation.
3.1 .1 .3  Effect o f caffeine on the 340/380 signal ratio increase in response to 
electrical stimulation at 1Hz.
Figure 50 is a trace showing the effect o f  perfusing Im M  caffeine on the 340/380 
signal ratio increase, representing calcium transients, in response to electrical 
stimulation. This trace is representative o f  8 similar experiments. It can be seen that 
while caffeine has no effect on the amplitude o f  the oscillations, the duration of the 
transients is increased. A concentration o f  lOOnM PIP i  appeared to have no effect 
on the increase in duration o f  the calcium transients (n =  3, data not shown).
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Figure 50
Trace showing the effect o f  caffeine on the fura-2 340/380 signal ratio increase in 
response to electrical stimulation at 1Hz, in a single myocyte, superfused at 2 ml/min. 
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These studies have primarily investigated the actions of novel derivatives o f  palmitoyl 
carnitine in the coronary vasculature and myocardium.
1. Structure-activity relationship studies, and the effect of verapamil on coronary 
constrictor and dilator responses to compound G.
The initial studies described involved the investigation into structure-activity 
relationships o f  various synthetic derivatives o f  palmitoyl carnitine in the isolated, 
perfused rat heart in order to elucidate the groups o f  the molecule required for the 
generation o f  a coronary dilator response.
1.1 Importance of the C terminus ester group on coronary dilator activity.
The parent molecule, palmitoyl carnitine (See Table 1 below for structures) has 
previously been shown to be a potent coronary constrictor in the isolated perused rat 
heart (Criddle et a l.,  1990). The conversion of this zwitterionic amphiphile to a 
cationic ester derivative, by the action of an alcohol, has been shown to convert the 
molecule from a coronary constrictor to a coronary dilator (Criddle et al., 1990).
The present study shows that the presence o f  an ester grouping is not necessary for the 
coronary dilator response. Compound A differs from the parent compound palmitoyl 
carnitine in the presence o f  an ethyl group at the C terminus, in place o f  a carboxylic 
acid group (see Table 1, Results). Like the isopropyl ester derivative o f  palmitoyl 
carnitine (P IP i) ,  Com pound A was found to be an active coronary dilator in the 
coronary circulation (Figures 8 , 9 &  10). Thus it appears that the absence o f  a 
negatively charged carboxylic acid group, producing a molecule with an overall
positive charge is the necessary requirement in the conversion o f  the molecule from a 
coronary constrictor to a coronary dilator. However, Com pound A produced a more 
pronounced transient coronary constriction preceding the dilator response than P IP i ,  
which may account for to the significantly smaller coronary dilator responses to 
lower doses o f  Com pound A than equivalent doses o f  P IP i .
Table 1
Structures o f  the palmitoyl carnitine derivatives used in this study.
Palmitoyl carnitine Palmitoyl carnitine Isopropyl ester (PIPi)
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Further structure-activity relationship studies were carried out in order to establish 
the groups attached at the N and C terminus of the carnitine moiety producing the 
optimum coronary dilator potency.
1.2 Effect of N terminus substitution on coronary dilator potency.
With regard to N terminus groups, the size o f  the groupings attached to the nitrogen 
considerably affect the charge on the nitrogen. As Compound E, containing only 2 
(methyl) groups attached to the nitrogen producing a tertiary nitro group and hence a 
neutral molecule, was found to be inactive as a coronary dilator, this suggests that 
the positive charge is essential for coronary dilator activity (Figure 11 & Table 2). 
This supports the finding, stated earlier, that the absence o f  the negatively charged 
(carboxylic acid) group from palmitoyl carnitine confers coronary dilator activity. In 
addition, Com pound F containing a morpholinyl group was a very weak coronary 
dilator, and this compound is only weakly protonated at pH 7.4, and hence carries 
less positive charge than the quaternary amm onium  compounds tested, which also 
indicates the importance of  the positive charge on coronary dilator activity.
In the case o f  palmitoyl carnitine derivatives containing a quaternary nitrogen group 
(Compounds A-F) the larger the size o f  the groups attached to the quaternary 
nitrogen, the lower the positive charge on the nitrogen, due to the electron donating 
effect of the larger alkyl groups. The results obtained show that there is no simple 
relationship between the size of  the positive charge and coronary dilator activity.
The pattern observed was that the larger the size o f  the groups attached to the 
nitrogen, up to three ethyl groups, the greater the coronary  dilator potency (Figure 
I I  & Table 2). Compound B (two methyls and one hydrogen) was significantly less 
potent and produced a significantly lower maximum dilator response than Compound 
A (three methyl groups) and Compound C (three ethyl groups) was significantly 
more potent than Compound A. However, the presence o f  three propyl groups 
attached to the nitrogen produces a compound with a potency not significantly
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different from Compound A. Thus it appears that although the positive charge on the 
nitrogen is essential for coronary dilator activity, it is the conformation of the N 
terminus rather than the density o f  the positive charge on the quaternary nitrogen 
which confers coronary dilator potency. In the case o f  the classic calcium channel 
antagonists, a positive charge is not required for vasodilator activity, suggesting a 
different mechanism of action o f  palmitoyl carnitine derivatives. However, it has 
been shown that the binding o f  charged dihydropyridine calcium antagonists is 
unexpectedly stable, eg. amlodipine (Kass et a l.,  1988), due to a different mode of 
binding to the active site on the D H P receptor (Ferrante et al., 1990).
1.3 Effect of C terminus substitution on coronary dilator potency.
The group attached at the C terminus o f  the molecule appears to be less critical in 
determining the coronary dilator potency o f  the compound. All compounds tested 
which contained the same groups attached to the nitrogen (three methyls) were 
equieffective in terms of the maximum dilator response achieved (Table 3).
However, Com pound J which contains an overall double positive charge, due to the 
presence o f  two quaternary nitrogen groups, was significantly less potent than 
Compound A (Table 3 & Figure 12b), confirming the suggestion that the magnitude 
of the positive charge is not directly proportional to dilator potency. In addition, 
Compound G, containing a hydrogen in place o f  a C terminus group was 
significantly less potent than Compound A, which may relate to the fact that this 
compound showed a very large coronary constrictor component (Figures 13 & 14). 
The addition o f  an arginine group to the C terminus o f  the molecule (Compound M) 
produced a compound with significantly lower potency than Compound A, and not 
significantly different from Compound A in terms o f  maximum dilation achieved 
(Table 3 &  Figure 12b). This suggests that Com pound M does not elicit an 
additional coronary dilator activity by acting as a substrate for NO production. The 
nitroarginine equivalent (Compound N) was similarly lacking in potency. 
Interestingly, however, Compound N produced the most prolonged coronary dilation
134
o f  any compound tested, which may be related to the conformation of the molecule 
with a very long C terminus grouping.
In sum m ary for all the structure-activity relationship studies, it is clear that an overall 
positive charge is essential for coronary dilator activity of  palmitoyl carnitine 
derivatives, but the magnitude o f  the positive charge is not directly proportional to 
coronary dilator potency. The conformation o f  the groups at the N terminus o f  the 
molecule is critical to the potency o f  the compound, whilst changes in the C terminus 
produce smaller changes in coronary dilator potency, provided the grouping is 
uncharged. Additionally, most of the compounds tested also produced a transient 
coronary constrictor component to the response (see below). None of the compounds 
tested had any effect on cardiac contractility at the doses used. As small changes to 
the palmitoyl carnitine molecule have such a profound effect on coronary dilator 
activity, it seems likely that the mechanism o f  action is due to a specific interaction 
rather than a non specific detergent effect. The fact that a positive charge is essential 
for coronary dilator activity suggests that the mechanism may involve alteration of 
the surface charge on the membrane o f  the smooth muscle cells.
Com pound G was selected for experiments investigating the mechanism underlying 
the coronary constrictor component of the response to the novel palmitoyl carnitine 
derivatives as this produced the greatest and most consistent coronary constrictor 
activity. The inhibition of the coronary dilator component of the response to 
compound G by the calcium antagonist verapamil is probably due to the fact that 
verapamil itself produced a large reduction in perfusion pressure (Figure 13), 
therefore allowing less scope for a coronary dilator response to Compound G. The 
inhibition o f  the coronary constrictor com ponent o f  the response to Compound G by 
verapamil (Figures 13 & 14) suggests that it is either directly or indirectly affecting 
calcium entry through L-type calcium channels. Criddle et a l . (1992; 1994) proposed 
that P IP i  inhibits voltage gated calcium channels in the mesenteric vascular bed, and 
thus the coronary  constrictor component o f  the response to these palmitoyl carnitine
derivatives may be via an opposing activation of  voltage gated calcium channels. 
Verapamil has been shown to produce other effects in vascular smooth muscle apart 
from calcium antagonist activity, namely a j-ad renocep to r  antagonist activity (Bhalla 
& Sharma, 1986; Muller & Noack, 1988). However, in smooth muscle membranes a 
concentration o f  10/xM verapamil was required to inhibit prazosin ( a r e c e p t o r )  
binding by 65-70% (Bhalla & Sharma, 1986), and therefore at the concentration used 
(lOOnM), verapamil is likely to exert mainly voltage gated calcium channel antagonist 
activity. Thus compound G, and hence other related palmitoyl carnitine derivatives, 
appear to be interacting with voltage gated calcium channels in some way, at least in 
eliciting the constrictor component to their response.
2. Effect o f high (llO m M , 20mM) potassium solutions and TEA on the coronary 
dilator response to PIPi.
These experiments were performed in order to investigate an involvement o f  P IP i  with 
potassium channels in vascular smooth muscle, and to compare the coronary dilator 
activity o f  P IP i  with potassium channel opening coronary dilators and calcium 
antagonists, to elucidate further the mechanism for the vasodilator effect elicited by 
P IP i  and related compounds. The calcium channel blocker verapamil was used as a 
reference compound for these experiments as this has been shown by Hamilton et al. 
(1986) to be active in the presence of high (80mM) potassium-induced depolarisation, 
while the potassium channel opener cromakalim was inactive, in the rat portal vein.
A concentration o f  l lO m M  K +  produced a depolarisation o f  the smooth muscle and 
the cardiac muscle which accounts for the increase in perfusion pressure, and the 
increase in resting tension and inhibition o f  contractility in the m yocardium, shown in 
these experiments (Figure 15).
The coronary  dilator responses to verapamil and nicardipine were not significantly 
affected in the presence o f  1 lOmM K +  perfusate suggesting that calcium channel
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blockers are unaffected by this perfusate. Papaverine is also considered to elicit a 
smooth muscle relaxation via inhibition of the calcium channel current (Iguchi et al., 
1992), and although part o f  its relaxant effect has been attributed to phosphodiesterase 
inhibition, this is not the case in smooth muscle where vasodilation has been shown to 
occur in the absence o f  any increase in intracellular cA M P (Fujioka, 1984). The 
dilator response to this com pound was also unaffected by l lO m M  K “*“ perfusate, 
indicative o f  an action via calcium channel inhibition. The potassium channel opener 
lemakalim (Edwards and W eston 1990) is the active enantiomer o f  cromakalim, 
thought to act mainly via ATP-dependent potassium channels (Standen et a l.,  1989), 
although other types o f  potassium channel may also be involved in the blockade (Bray 
& Quast, 1991). The coronary  dilator response to P IP i,  as well as to the potassium 
channel opener lemakalim, was completely inhibited by the presence of  l lO m M  K +  
perfusate (Figure 16). This concentration o f  potassium depolarises the smooth muscle 
cells to -6 mV, assuming the sarcolemma to be permeable to potassium ions only, 
calculated by the Nernst equation, shown in the 'Results' section. This greatly reduces 
the driving force for potassium efflux through potassium channels as the external 
potassium concentration is almost as high as the concentration within the smooth 
muscle cells. Hence, this prevents action o f  dilators which act via the opening of 
potassium channels and cell hyperpolarisation (Hamilton et al., 1986; Weir and 
Weston, 1988). As the coronary  dilator action o f  P IP i,  as well as the potassium 
channel opener lemakalim, was inhibited under l lO m M  K +  conditions, this indicates 
a mode o f  action o f  P IP i  via the activation o f  potassium channels in smooth muscle. 
The fact that the response to salbutamol was also reduced in the presence o f  1 lOmM 
K +  may be related to the fact that there was a tachyphylaxis shown to the coronary 
dilator effect o f  salbutamol in control preparations (Figure 17). However, the 
inhibition was even greater in the presence o f  l lO m M  K +  perfusate, and there is 
evidence to suggest that ft-adrenergic agonists are able to increase K “*~ currents 
(Bennett et a l.,  1986; Walsh & Kass, 1988; W ickenden &  Ellis, 1991). Thus part of 
the vasodilator effect may be mediated by the opening of  potassium channels in 
smooth muscle cells and this component can be inhibited in the presence o f  1 lOmM
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potassium. The fact that the coronary dilator response to PIPi in the presence of 
l lO m M  K +  was different to that of verapamil and nicardipine is indicative of a 
different mechanism of  action to that o f  the classic calcium channel antagonists. 
However, the results contradict those of  Criddle et al. (1992; 1994), who showed 
that P IP i  was able to attenuate calcium-induced constrictions in the llO m M  K +  
depolarised mesenteric vascular bed.
Experiments were also performed in the presence o f  20m M  K +  , as this 
concentration produces a degree of  depolarisation within the vascular smooth muscle 
cells (from the Nernst equation, assuming sarcolemma to be permeable to potassium 
ions only, potential difference across sarcolemma =  -51mV in the presence o f  20mM  
K +  , see Results), but does not prevent the outward gradient for potassium following 
the activation o f  K +  channels. Hamilton et al. (1986) showed that the potassium 
channel opener cromakalim could still inhibit calcium-induced constrictions in the rat 
portal vein in the presence o f  20mM  potassium, but not in the presence o f  l lO m M  
potassium. The fact that P IP i  responses were significantly reduced but not abolished 
in the presence o f  20m M  K +  perfusate (Figure 18) also points to a mode o f  action 
involving potassium channel opening, as the driving force for K +  efflux will be 
reduced but not abolished.
Experiments were also carried out using TEA in order to follow up the hypothesis 
that P IP i  produces a coronary dilator response via the opening o f  K +  channels. 
Criddle et al. (1994) found that glibenclamide had no effect on the vasodilator 
response to P IP i .  This agent is a blocker o f  ATP-dependent K +  channels (Sturgess 
et a l.,  1988; Zunkler et al., 1988), although recent evidence has suggested an 
additional action, namely modulation of  the dihydropyridine binding site o f  L-type 
calcium channels (Bian & Hermsmeyer, 1994). Lemakalim which was also inhibited 
in l lO m M  K +  experiments acts via activation o f  ATP dependent K channels. 
Therefore there is the possibility that another type o f  potassium channel is involved 
in the response to P IP i ,  and so a less specific potassium channel blocker TEA (Cook
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& Quast, 1990) was used to investigate this. TEA is able to block delayed (outward) 
rectifier K +  channels, inward rectifier channels, high conductance Ca^ +  activated 
channels and sodium activated K +  channels, and is also a weak blocker of the other 
classes of  potassium channels (Cook, 1988). It has also been shown to exhibit 'non­
specific' effects, ie. effects other than K “*“ channel block at higher concentrations eg. 
block of  muscarinic and nicotinic receptors. The fact that a high (lOmM) 
concentration o f  TEA  produced only a weak inhibition o f  the P IP i  response (Figure 
19), together with the lack o f  effect o f  glibenclamide shown by Criddle et al. (1994) 
suggests that potassium channel activation is not the principal mode of action of 
P IP i .  This contradicts the results obtained with high (1 lOmM) potassium solution. 
However it is important to note that in other perfused vascular preparations eg. the 
mesenteric vascular bed (Criddle et al., 1992; 1994) the actions of P IP i were not 
prevented in l lO m M  K +  depolarised preparations and therefore this also contradicts 
results obtained in the coronary vasculature and indicates differential effects in 
different vascular preparations.
3. Effects of PIPi on responses to BAY K 8644, PGF2a> noradrenaline, 
methoxamine, caffeine and a low sodium perfusate in the isolated perfused rat 
heart.
3.1 The effect o f PIPi on BAY K 8644 responses in the isolated rat heart.
These experiments were originally performed in order to investigate the interaction of 
P IP i  with various coronary constrictor drugs in order to elucidate the mechanism for 
the coronary dilator action o f  P IP i.  In the case o f  experiments investigating the 
interaction with BAY K 8644, the interpretation of  results was more simple as bolus 
doses o f  this compound produced a dose-dependent coronary constrictor effect with 
no concomitant effect on heart rate or developed tension (Figure 20). The lack of
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effect of BAY K 8644 on developed tension was unexpected as this compound has 
been shown to produce a positive inotropic effect in cardiac muscle (Thomas et al., 
1985; Bohm et a l.,  1985), but it could relate to the fact that the doses required to 
produce a large coronary constrictor effect were insufficient to produce any effect on 
the cardiac myocytes. The ability o f  P IP i  to attenuate the coronary constrictor action 
o f  the L-type calcium channel activator BAY K 8644 (Schramm et al., 1983; Thomas 
et a l.,  1985) in a concentration-dependent manner (Figure 21) indicates that P IP i  is 
able to exert an inhibitory action on L-type calcium channel activation in coronary 
smooth muscle. This supports the earlier findings o f  Criddle et. al. (1992; 1994), who 
showed that P IP i  could inhibit calcium-induced contractions in perfused, potassium 
depolarised vascular beds. However, the data obtained from experiments using 
l lO m M  potassium depolarised rat hearts indicates that the action of P IP i  differs from 
the actions o f  classical calcium channel antagonists. It is possible that P IP i  may be 
exerting an inhibitory effect on BAY K 8644-induced contractions by affecting 
calcium-induced calcium release from the sarcoplasmic reticulum produced following 
calcium entry (Ito et al., 1991). This is not a likely explanation, however, since P IP i,  
as a positively charged amphiphile, is unlikely to be able to cross the sarcolemma 
(Katz, 1992) and hence probably exerts its effect through a cell surface interaction. 
Additionally, the coronary constrictor effect induced by a low sodium perfusion, 
described later, was not affected by the presence of P IP i ,  and this also has a calcium- 
induced calcium release component.
3.2 The effect of PIPi on PGF2 a  responses in the isolated rat heart.
PG F 2a  has been shown to constrict coronary vessels (Nyborg & Mikkelsen, 1985; 
Schror, 1993) via activation o f  PF prostaglandin receptors and possibly also 
thromboxane (TX) receptors (Schror, 1993), and hence the interaction o f  P IP i  with 
this compound was also investigated, to test the specificity o f  the inhibitory action of 
P IP i  on BAY K 8644-induced coronary constriction. In this study, however, PG F2a
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produced only a very weak coronary constrictor effect (Figure 27). This could be due 
to a  low num ber o f  PF receptors in the coronary smooth muscle o f  this preparation or 
possibly due to P G F 2a -induced release of vasodilator prostaglandins eg. prostacyclin 
(D eDeckere &  Ten Hoor, 1980; Godfraind & Miller 1987) which would counteract 
the constrictor action of PG F2a . Flowever, an unexpected positive inotropic effect 
was produced in response to PG F2a  which has seldom been reported previously, 
although Karm azyn et al. (1981) did report a positive inotropic effect o f  PG F2a  in the 
isolated rat heart. The second messenger system triggered following PF receptor 
stimulation is generally reported to be phospholipase C / IP3 / DAG (Hatanaka et al., 
1989; Colem an et a l.,  1994), although PG F2 a  has also been shown to be a potent 
inhibitor o f  N a + -K +  ATPase and thus could possibly exert a positive inotropic effect 
in a similar manner to that o f  the cardiac glycosides (Karmazyn et a l., 1981).
Although some prostaglandins have been shown to exert a  positive inotropic effect via 
elevation o f  intracellular cAM P, this was found not to be the case for PG F2 a  
(Kangasaho et. al., 1978). A very low concentration (lOnM) o f  P IP i  was found to 
completely inhibit the positive inotropic effect o f  PG F 2a  while having no effect on 
basal contractility (Figures 27 & 28). As the precise mechanism for the PG F 2a - 
induced positive inotropic effect remains unclear, this does not help elucidate the 
mechanism o f  action of P IP i. Flowever, it does indicate that P IP i  is able to gain 
access to the cardiomyocytes during coronary perfusion in the isolated rat heart 
preparation, and therefore this refutes the possibility that P IP i  does not affect basal 
contractility because o f  the inability to access the myocardium.
3.3 The effect of PIPi on noradrenaline responses in the isolated rat heart.
In order to investigate further the inhibitory action o f  P IP i  on positive inotropic 
responses, the effect of PIP i on the positive inotropic agent noradrenaline was 
investigated. This agent was found to produce more complex effects on the three 
parameters measured. In terms o f  effects on the coronary vasculature, the initial
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coronary constrictor effect is probably mediated by a combination of a ]  and 0,2 
receptor stimulation (Heusch et al., 1984) plus a mechanical effect produced as a 
consequence of the positive inotropic action. The coronary dilator component is 
probably mediated mainly via 62 receptor activation (Gross & Feigl, 1975) and 
metabolic dilation, induced via the release o f  adenosine and dilator prostaglandins as a 
consequence of the large positive inotropic effect and increased workload o f  the heart 
(Zuberbuhler & Bohr, 1965). At higher doses of noradrenaline, this coronary dilator 
effect masked the coronary constrictor effect completely, thus making measurement of 
the effect o f  P IP i  on coronary constrictor responses to noradrenaline impossible 
(Figure 22). Although coronary vascular effects are markedly affected by changes in 
myocardial contractility, it has been shown previously that the reverse is not true ie. 
coronary perfusion pressure changes do not markedly affect cardiac contractility 
(Baydoun & W oodward, 1991), therefore studies using noradrenaline as an agonist 
concentrated mainly on examining the effect o f  PIP i on the changes in myocardial 
contractility induced by this agent.
Noradrenaline produced a biphasic positive inotropic effect, and a monophasic positive 
chronotropic effect. The initial positive inotropic effect is probably mainly a 
consequence o f  the increase in heart rate, as sequentially increasing heart rate in the 
pacing experiments was found to produce an immediate increase in cardiac 
contractility (Figure 33), possibly via release o f  transmitters, eg. noradrenaline, due to 
stimulation o f  nerves in the myocardium. Therefore, only the second phase of the 
inotropic response was measured in these experiments. Positive inotropic and 
chronotropic responses to noradrenaline are mediated by stimulation o f  B- 
adrenoceptors in the m yocardium (Ahlquist, 1948), mainly o f  the Bj subtype 
(Molinoff, 1984). In the present studies, the 6 [-adrenoceptor antagonist atenolol 
virtually abolished both responses, indicating that the positive inotropic and 
chronotropic effects were mediated mainly via -adrenoceptor stimulation in this 
preparation. Noradrenaline has been shown to produce an a-adrenoceptor mediated 
positive inotropic response in the presence o f  B blockade (Ask Sc Stene-Larsen, 1984) in rat
m yocardium , but this effect was not seen in these studies. The B\-adrenoceptor 
mediated positive inotropic effect is due to G protein (Gs) stimulation o f  the adenylyl 
cyclase / cA M P / protein kinase A cascade followed by phosphorylation of L-type 
calcium channels which leads to an increase in calcium entry in cardiac myocytes 
(Sperelakis, 1988; Robishaw & Foster, 1989). Calcium channel activation in response 
to B adrenergic agonists in cardiac myocytes has also been shown to occur via a direct 
G protein pathway independently o f  intracellular cA M P (Yatani et a l., 1987; Yatani & 
Brown, 1989). However, this is probably not an important pathway physiologically, 
due to a basal regulation of calcium current by Gg, and increased activity above basal 
current requires phosphorylation (Hartzell et al., 1991; Harzell & Fischmeister,
1992). The chronotropic effect o f  noradrenaline is due to Bj-adrenoceptor mediated 
activation o f  the pacemaker current, If, a hyperpolarisation activated N a +  and K"*" 
inward current in the SA node, and both cA M P dependent phosphorylation and a 
direct effect o f  cA M P is thought to contribute to the activation o f  If (DiFrancesco, 
1993; DiFrancesco & Mangoni, 1994). The ability o f  P IP i  to inhibit the positive 
inotropic action o f  noradrenaline while having no effect on its chronotropic activity 
(Figures 23 & 24) was interesting, and the fact that atenolol inhibited both the positive 
inotropic and chronotropic effects o f  noradrenaline (Figures 23 & 24) indicates that 
P IP i  is not having a selective effect on the inotropic response simply due to poor 
perfusion o f  the drug to the SA node. The effect o f  P IP i  to supress positive inotropic 
responses to noradrenaline was shown in separate experiments to be reversible (Figure 
32) and therefore the effect is not due to a non specific toxic effect o f  the compound, 
due to m em brane disruption by the compound. As P IP i  did not affect either basal 
heart rate or the chronotropic action o f  noradrenaline, this indicates that it is not 
inhibiting pacem aker current, Bj-adrenoceptors or cA M P production. This also 
implies that P IP i  is not acting in a similar manner to muscarinic agonists, or 
adenosine, to inhibit B mediated positive inotropic responses via decreasing 
intracellular cA M P (Belardinelli & Isenberg, 1983; Robishaw Sc Foster, 1989; Fenton 
et a l.,  1991; Shyrock et al., 1993), as these two agents also inhibit the positive 
chronotropic response via a similar mechanism (DiFrancesco Sc Tromba, 1988).
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These observations therefore point to an interaction with L-type calcium channels as 
the most likely site o f  action o f  PIP i in inhibiting the inotropic response to 
noradrenaline. The lack o f  effect o f  PIP i on basal cardiac contractility contrasts with 
its effect under noradrenaline stimulated conditions. Hence it appears that P IP i is 
able to exert its inhibitory effect on phosphorylated L-type channels in cardiac 
myocytes. This possibility requires further investigation.
The direct coronary dilator effect o f  noradrenaline is mediated mainly via B2 - 
adrenoceptors (Molinoff, 1984). However, in whole heart preparations, a metabolic 
vasodilation linked to an increased workload o f  the heart is also likely to contribute 
to the coronary dilator effect (Zuberbuhler & Bohr, 1965). The inhibition o f  the 
coronary dilator effect o f  noradrenaline by the G^-selective antagonist atenolol and by 
P IP i  (Figure 25) is most likely to be due to a reduction o f  metabolically induced 
vasodilation, via an inhibition o f  the positive inotropic effect induced by these two 
agents, and additionally, inhibition o f  the positive chronotropic effect in the case of 
atenolol. There is evidence for -adrenoceptor mediated coronary dilation in the rat 
heart (Nyborg & Michelsen, 1985) which may also account for some of  the atenolol 
mediated reduction in the coronary dilator response. The metabolic dilation 
produced in response to an increase in heart rate is shown clearly in the pacing 
experiment shown in Figure 33.
The effects o f  the positively charged amphiphile polymyxin B, which has been shown 
to reduce ion fluxes in myocytes due to alteration of  membrane surface charge (Burt 
et al., 1983), and palmitoyl carnitine, the parent molecule of P IP i, on the positive 
inotropic response were investigated in order to establish the importance o f  the 
positive charge in the inhibitory effect o f  P IP i. As polymyxin B was not able to 
significantly alter the positive inotropic response to noradrenaline (Figure 26), this 
indicates that the effect o f  P IP i  to reduce these responses is not solely due to the tact 
that it is a positively charged amphiphilic substance. However, as palmitoyl carnitine 
was also ineffective, the positive charge o f  P IP i  is important in the inhibitory effect.
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3.4 Effect o f PIPi on methoxamine responses in the isolated rat heart.
Although noradrenaline is an agonist at both a  and B adrenoceptors, in these studies its 
actions appeared to be mediated mainly via the activation o f  B receptors within the 
myocardium. Also, the dilator effect o f  noradrenaline masked the a  mediated 
constriction in the coronary vasculature. Therefore, the a  selective agonist 
methoxamine was used to investigate the effect o f  P IP i  on a  mediated responses, in 
both the myocardium and coronary vessels. The effect o f  P IP i  on responses to a B 
selective agonist eg. isoprenaline was not used, as preliminary experiments showed 
this compound to depress basal coronary contractility following the positive inotropic 
effect to such an extent that dose response curves could not be constructed. 
M ethoxamine produced a variable effect on perfusion pressure, a monophasic positive 
inotropic effect and no concomitant effect on heart rate. Stimulation o f  a -  
adrenoceptors is able to produce vasoconstriction (Molinoff, 1984), however the lack 
o f  a consistent coronary constrictor effect in this preparation may be due to an 
opposing metabolic vasodilation, similar to that described for noradrenaline (see 
Discussion, section 3.3), although a marked coronary dilator effect was not observed 
in response to methoxamine. The fact that the positive inotropic response was 
monophasic, unlike noradrenaline which showed a biphasic positive inotropic response 
may reflect the absence of any increase in heart rate shown in response to 
methoxamine, and this is likely to be responsible for the initial positive inotropic 
response produced by noradrenaline. M ethoxamine is believed to produce a positive 
inotropic response in the absence o f  any increase in the calcium inward current in 
isolated cardiomyocytes (Hartmann et a l., 1988; Terzic et a l., 1991; Puceat et al., 
1992), although some studies have reported an increase in slow inward current in 
response to a-adrenoceptor agonists, independent o f  cA M P (Lindemann, 1986; Otani 
et al., 1988; Fedida et al., 1993), via protein kinase C induced phosphorylation of L- 
type calcium channels in the myocytes (Lacerda et al., 1988). Michel et a l .,(1994) 
have suggested that the calcium influx is produced only by stimulation o f  oqA
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receptors and not o q g  receptors, and cqA  receptors were found to function in the rat 
ventricle only in the presence o f  o q g  receptor blockade; this suggests that calcium 
entry is not an important mechanism in the effect of a \-ad renocep to r  agonists 
physiologically. Alpha 1-adrenoceptor agonists are believed to produce a positive 
inotropic effect via myofilament sensitization (Puceat et al., 1992), ie. in a manner 
independent o f  an increase in intracellular calcium. The effector mechanism 
following oq-adrenoceptor  stimulation in myocytes is G protein activated 
phospholipase C induced phosphatidylinositol (1,4,5) bisphosphate hydrolysis 
yielding inositol (1 ,4 ,5) triphosphate and diacyl glycerol (Brown e ta l . ,  1985; 
W oodcock et al., 1987; O t a n i e t a l . ,  1988; F e d id a e ta l . ,  1993). Diacyl glycerol 
mediated activation o f  protein kinase C is believed to enhance myofilament 
responsiveness to calcium via phosphorylation o f  the Na +  - H +  exchanger producing 
an intracellular alkalinisation (Terzic et al., 1991; Fedida et al., 1993; Gambassi et 
al., 1992) and direct phosphorylation of contractile proteins (Puceat et a l., 1990).
The role o f  inositol triphosphate (IP3 ), which can produce a release o f  calcium from 
the sarcoplasmic reticulum, in the inotropic effect believed to be unimportant in 
myocardial cells (W oodcock et al., 1987; Langer, 1992). The fact that P IP i  
inhibited a \-a d re n o c e p to r  agonist-induced increases in cardiac contractility whilst 
having no effect on basal contractility (Figure 29), and that the cq-m ediated  positive 
inotropic effect occurs in the absence of any increase in intracellular calcium suggests 
that PIP i is not acting via a supression of calcium influx through L-type channels in 
these experiments, as was suggested as the mechanism for inhibition o f  B-mediated 
positive inotropic responses in previous experiments. This suggests that P IP i  can 
exert an inhibitory action on second messenger systems other than the adenyl cyclase 
/ cA M P / protein kinase A cascade and L-type calcium channel activation. In the 
case of  supression o f  oq mediated positive inotropic responses (and possibly also 
PG F2 oFmediated positive inotropic responses, which may involve a similar 
mechanism to methoxamine responses as PIP9 hydrolysis is a known effector 
mechanism for P G F 2a  (Hatanaka et al., 1989; Coleman et al., 1994)), a possible 
mechanism o f  action is via inhibition of protein kinase C. This action has been
shown for other cationic amphiphiles (Epand & Lester, 1990; Bottega Sc Epand,
1992) eg. polymyxin B (Raynor et a l., 1991), as well as for zwitterionic membrane 
stabilizers (Bottega Sc Epand, 1992) eg. the parent molecule palmitoyl carnitine 
(Wise et a l.,  1982; Epand Sc Lester, 1990). Bottega Sc Epand (1992) also suggest 
that compounds which are both cationic, particularly quaternary ammonium 
compounds, and membrane stabilizers would be the most potent inhibitors o f  protein 
kinase C, which would make PIP i a likely candidate for this action. These results 
point to another mechanism of action, possibly by affecting receptor-second 
messenger coupling, or possibly by inhibiting specific protein kinases. The fact that 
polymyxin B is also an inhibitor o f  protein kinase C, but did not exert the same 
inhibitory effect as P IP i on inotropic responses suggests that P IP i has a different 
mode o f  action. However, other reports have shown that polymyxin B is required in 
higher concentrations than were used in this study in order to inhibit protein kinase C 
activation (Raynor et al., 1991), with an EC50  o f  approximately 20/zM. The 
concentration of 1/xM was chosen for this study in order to investigate the effects of 
the molecule due to charge, and this concentration would produce an even greater 
increase in surface positive charge than the concentration o f  P IP i (lOnM) which 
produced an inhibitory effect on positive inotropic responses.
3.5 Effect of PIPi on caffeine responses in the isolated rat heart.
Caffeine was required in much higher doses to elicit effects in the isolated perfused 
rat heart than other agents used. This is because it does not act via activation of 
specific membrane receptors like the other agents studied. It produced a transient 
variable positive inotropic effect and a transient coronary constrictor effect followed 
by a longer lasting coronary dilator component (Figure 30). Caffeine is a 
phosphodiesterase inhibitor (Butcher Sc Sutherland, 1962), and this is likely to 
contribute to both the positive inotropic (Bers, 1985; Rousseau Sc Meissner, 1989) 
and the coronary dilator (Van Breemen Sc Saida, 1989) effect o f  caffeine, through an
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increase in intracellular cA M P levels in cardiac and coronary smooth muscle, if basal 
levels of cA M P are present. Caffeine also increases calcium release from the 
sarcoplasmic reticulum, via stimulation of sarcoplasmic reticulum ryanodine 
receptors (Van Breemen & Saida, 1989; Watanabe et al., 1992) and this is probably 
the mechanism for the coronary constrictor action produced by caffeine. As PIPi 
failed to inhibit the coronary constrictor effect o f  caffeine (Figure 31), this indicates 
that it is not acting via inhibition o f  ryanodine receptors o f  the sarcoplasmic 
reticulum to inhibit calcium release.
3.6 The effect of PIPi on the response to low sodium perfusion in the isolated rat 
heart.
Low sodium perfusion produced complex effects in the isolated perfused rat heart
preparation (Figure 36). The initial coronary constrictor effect and the positive
inotropic effect are likely to be due to increase in intracellular calcium produced by
perturbation o f  the Na +  - C a ^ +  exchange process, shown to occur in both vascular
smooth muscle (Batlle et al., 1991) and cardiac muscle (Bridge et al., 1990;
Philipson, 1990). Other cationic amphiphiles have been shown to inhibit this
exchange process (Philipson et al., 1985; Hilgemann & Collins, 1992) through an
effect on m em brane surface charge, possibly to oppose stimulation by negatively
charged phospholipids in the sarcolemma (Collins & Hilgemann, 1993). An
inhibition has also been reported for the parent com pound palmitoyl carnitine
(Philipson & Nishimoto, 1982; Lamers et a l., 1984). However, the lack of effect of
P IP i  on the positive inotropic or the coronary constrictor responses shows that under
+ 2 +
the conditions studied, it is not having any significant effect on Na -Ca exchange 
across cardiac muscle and coronary smooth muscle cells. The lack of effect is not 
due to the fact that we are seeing a supramaximal effect o f  low sodium as lowering 
the sodium chloride concentration below 59m M , as shown in the concentration-effect 
curve to sodium chloride in Figure 34 and Figure 35, results in even greater positive 
inotropic and coronary constrictor responses. As with the coronary
constrictor response produced by BAY K 8644, calcium-induced calcium release from 
the sarcoplasmic reticulum will be involved in the positive inotropic (Rich et a l .,
1988; Bers, 1985; Leblanc & Hume, 1990; Kohmoto et a l.,  1994) and coronary 
constrictor (Ito et a l., 1991) effects o f  low sodium perfusion. As P IP i had no effect 
on either o f  these parameters, this provides evidence to suggest that P IP i  is not 
affecting calcium-induced calcium release, in agreement with the results obtained for 
caffeine in the coronary vasculature. Low sodium perfusion also produced a decrease
in heart rate (bradycardia) due to hyperpolarisation o f  the pacemaker cells. Under
+ 2 +
normal conditions, Na -Ca exchange is electrogenic, three sodium ions entering the 
cell being exchanged for one calcium being extruded (Philipson & Nishimoto, 1980). 
Therefore, a  decrease in this exchange will produce a more negative m embrane 
potential. T he  lack o f  effect o f  P IP i  on this bradycardia is further evidence to suggest 
that P IP i  does not inhibit Na~*“-Ca2 +  exchange or the pacemaker current If. The 
secondary coronary dilator component o f  the response to low sodium occurs as a 
consequence o f  the positive inotropic effect, as previously described for noradrenaline, 
ie. release o f  vasodilator metabolites linked to the increased workload o f  the heart 
(Zuberbuhler and Bohr, 1965). The inhibition o f  these dilator responses by P IP i  is 
more difficult to explain but could possibly be inhibiting the release o f  vasodilator 
metabolites, or the coupling o f  these metabolites' receptors to their respective second 
messenger systems. The latter explanation would be in agreement with the inhibition 
by P IP i  o f  agonist-induced positive inotropic responses in the myocardium.
3 .7  Summary of the effect of PIPi on responses to various agonists in the isolated 
rat heart.
In sum m ary , in vascular smooth muscle, P IP i  was found to inhibit the coronary 
constrictor responses to the calcium channel activator BAY K 8644, but not responses 
to a  low sodium  perfusion or caffeine. In the m yocardium , P IP i  was found to have no 
effect on basal contractility, but inhibited the positive inotropic responses to PG F2 a^
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noradrenaline and methoxamine, but not the response to low sodium perfusion. In 
addition, a high (H O m M ) potassium perfusion inhibited PIPi-induced coronary 
dilation, but not verapamil-induced dilation.
The fact that both caffeine-induced coronary constriction, and low sodium mediated 
coronary constriction and increase in myocardial contractility, all o f  which have a 
calcium release component (see above), were unaffected suggests that the 
mechanism(s) o f  action o f  P IP i  does not include modulation of sarcoplasmic reticulum 
ryanodine receptors. This can also be considered unlikely on the grounds that as a 
cationic com pound, P IP i  is unlikely to be able to cross the sarcolemma (Katz, 1992), 
and therefore it probably exerts its action on the outer sarcolemmal surface. The 
ability o f  P IP i  to inhibit BAY K 8644-induced coronary constriction indicates that 
P IP i  is able to inhibit L-type C a ^ +  channel activation, and this is supported by its 
ability to inhibit B-mediated positive inotropic responses within the myocardium. Post 
et. al. (1991) described similar effects for the positively charged amphiphile dodecyl 
trim ethylam monium  (D D TM A ), which inhibited the calcium current through L-type 
channels in myocytes, an effect attributed to a change in the surface charge and hence 
transmem brane potential. However, the inhibition o f  methoxamine and PG F2 a ' 
induced positive inotropic responses does not fit this theory. The mechanisms by 
which noradrenaline, methoxamine and possibly P G F 2 a  exert a positive inotropic 
effect involves phosphorylation processes, either by protein kinase A or protein kinase 
C. Epand (1987) suggested that substrate phosphorylation by protein kinase C can be 
inhibited by positively charged compounds, and it is possible that protein kinase A 
mediated phosphorylation may be inhibited in the same manner. The ability of second 
messenger mediated protein phosphorylation to activate ion channels or ion transport 
systems has been suggested to be due to the incorporation o f  an anionic (phosphate) 
group on the m em brane surface, thus decreasing the potential across the sarcolemma 
and increasing m em brane excitability (Katz, 1992), and cations may therefore counter 
this effect. It is possible that following incorporation o f  P IP i  into the outer 
sarcolemmal leaflet, by way of  its fatty acid chain, close to the membrane proteins, it
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may counteract the effects o f  protein phosphorylation by means of  the positively 
charged quaternary nitrogen group. In the case o f  6 mediated positive inotropic 
responses ie. in response to noradrenaline-induced stimulation, the phosphorylation 
sites are on the ot| and ft subunits o f  the L-type calcium channel (Catterall & 
Striessnig, 1992), and P IP i could be affecting calcium currents by countering the 
effects o f  phosphorylation at this site. Pacemaker activity in the SA node cells of the 
myocardium is regulated by the hyperpolarisation activated current, If, carried by 
N a -1- and K +  ions, although other current (eg. calcium current through T-type 
channels and cA M P regulated chloride current) are also believed to be involved 
(DiFranceso, 1993). The main current responsible for pacemaker activity is If, and 
the fact that increases in heart rate were unaffected by P IP i  also agrees with this 
hypothesis, as cA M P is able to control the activity o f  this current directly, a 
mechanism which is now considered to be more important than via protein kinase A 
induced phosphorylation o f  the channel (DiFrancesco, 1993; DiFrancesco & 
Mangoni, 1994). A direct G protein activation o f  If in pacemaker cells (Yatani et 
al., 1990) has also been suggested. The main mechanisms of  activation of If are 
therefore largely independent o f  phosphorylation, which may explain the lack of 
effect of P IP i  on noradrenaline-induced increases in heart rate and hence the 
pacemaker current. Doolan & Keenan (1994) reported an inhibitory action of fatty 
acids eg. arachidonic acid on protein kinase A-induced phosphorylation, and PIPi 
may be acting similarly. In the case of the a  [-adrenoceptor mediated methoxamine 
responses, P IP i  may be modulating sarcolemmal protein kinase C activity.
Therefore in this case inhibition o f  the protein kinase C phosphorylation-activated 
N a “*“- H +  exchanger is a possible mechanism of  action for PIPi-induced inhibition ot 
positive inotropic responses in these experiments. The main direct effects o f  protein 
kinase C are in the sarcolemma, as it requires the correct lipid environment for 
activation ie. the presence o f  negatively charged m em brane phospholipids eg. 
phosphatidyl serine, phosphatidyl inositol, phoshatidic acid (Oishi e t a l . ,  1988; Epand 
& Lester, 1990: Sando et al., 1992). Effects o f  protein kinase C to activate 
myofilaments could involve the activation o f  a kinase cascade, as alone it is
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insufficient for activation o f  the myofilaments (Puceat et al., 1990), and therefore a 
sarcolemmal effect o f  P IP i  could also interfere with this cascade. The fact that 
protein kinase C requires an association with negative amphiphiles (phospholipids) for 
activity has led to the proposal that positively charged amphiphiles exert their 
inhibitory effect by opposing this interaction, following incorporation into the 
sarcolem m a (Epand & Lester, 1990), and P IP i  may also be acting in this way.
Another possible explanation for the inhibition by P IP i  o f  the receptor mediated 
positive inotropic responses but not the low sodium perfusion mediated positive 
inotropic response is a direct G protein interaction, which has previously been shown 
with other cationic amphiphiles, eg. substance P (Mousli et al., 1990). However, 
very high concentrations are required for this charge dependent effect, and the 
mediators are generally doubly charged and therefore it seems unlikely that P IP i is 
acting through a direct G protein mechanism. In addition, the fact that P IP i  does not 
affect the pacem aker current If, which is also mediated via a G protein pathway 
(DiFrancesco, 1993), also indicates that P IP i  is unlikely to act via a direct interaction 
with G proteins.
The fact that P IP i  produces a coronary dilation with no effect on basal contractility 
(this study; Criddle et. al., 1990) suggests a different mode of action within vascular 
smooth muscle to that in the myocardium. In addition, the ability o f  PIP i to 
antagonise BAY K 8644-induced contractions suggests an ability to affect calcium 
channel currents independent o f  phosphorylation in smooth muscle. However the 
possible interaction o f  P IP i  with membrane surface charges could also explain these 
effects. A more negative transmembrane potential close to the calcium channels in 
smooth muscle, which could occur following binding o f  positively charged P IP i ,  may 
affect the voltage gating of the channel and hence opening o f  the calcium channel 
(Green & Andersen, 1991; Latorre et al., 1992). The fact that basal myocardial 
contractility is unaffected may be due to the relative contribution o f  calcium entry and 
release from the sarcoplasmic reticulum on basal contractility in this cell type. In rat
myocytes, calcium entry through L-type calcium channels is insufficient to activate 
myofilaments directly, but a small influx o f  calcium is amplified through calcium- 
induced calcium release from the sarcoplasmic reticulum, which then activates the 
contractile filaments (Fabiato, 1983; Rich e t a l . ,  1988; Bers, 1985; Langer, 1992). 
This initial calcium entry which triggers calcium release may also be mediated by 
sodium influx, and subsequent calcium entry via the N a ^ - C a ^  +  exchanger (Leblanc 
& Hum e, 1990; Kohmoto et a l., 1994), as well as entry through L-type calcium 
channels. In terms o f  vascular smooth muscle, the earlier findings that P IP i  only 
exerted a relaxant effect in the microvasculature and not in conduit vessels (Criddle et 
a l., 1992) is further evidence for an effect only on the sarcolemmal surface, to modify 
ion currents via a charge effect, as agonist-induced release o f  sarcoplasmic reticulum 
calcium is more prominent in the large conduit arteries, but is diminished in smaller 
arteries, where calcium entry is more important (Goldman et al., 1988). Thus the lack 
o f  effect o f  P IP i  on conduit vessels may be due to the same reason as the lack of 
effect on basal contractility within the myocardium.
The inhibition o f  the coronary dilator response to P IP i  by high potassium perfusion 
may also be explained by the membrane charge effect. The high degree of 
depolarisation o f  smooth muscle cells achieved by l lO m M  K +  perfusion may counter 
the increase in negativity o f  the transmembrane potential which could be responsible 
for the dilator action o f  the positively charged amphiphile P IP i ,  thus preventing the 
coronary  dilator response. It appears unlikely that P IP i  is exerting a direct effect on 
potassium channels as neither glibenclamide (Criddle et a l. ,  1994) nor TEA (this 
study) abolished coronary dilator responses to P IP i .  How ever, it could be producing 
a similar effect to potassium channel openers, through increasing the positive charge 
on the outer sarcolemmal surface and thus producing a more negative transmembrane 
potential, an action which has been described for other cationic amphiphiles (Post et 
al., 1991). Potassium channel openers, by hyperpolarising the cell, also increase the 
transmem brane potential, thus reducing m em brane excitability and rendering the cell 
more resistant to activation by agonists (Quast et a l., 1994). In previous studies in the
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mesenteric vascular bed o f  the rat (Criddle et al., 1992; 1994), the finding that PIPi 
was still able to prevent calcium-induced vasoconstrictor responses may be due to the 
fact that higher concentrations o f  P IP i  were used to counter the depolarisation. There 
may also be differences in the resting membrane potential in the two preparations. 
Chappell et al. (1990) found that in pulmonary vessels, much higher external 
potassium concentrations were required to inhibit 1/xM lemakalim mediated relaxation 
in small pulm onary vessels than in large vessels, and additionally, a low (0.1/zM) 
concentration o f  lemakalim was able to maximally relax the low potassium-depolarised 
small vessel while having no effect in the large vessel. These effects were attributed 
to differences in resting m em brane potential.
3.8 Comparison of the effects o f palmitoyl carnitine with those of PIPi in these 
studies.
The parent molecule, palmitoyl carnitine did not share the properties o f  the isopropyl 
ester derivative in isolated perfused heart studies. However, it has been shown in 
erythrocyte electrophoretic mobility (EPM) studies that palmitoyl carnitine itself 
confers a positive charge on the membrane surface (Meszaros et. al., 1988) and this 
has been suggested as a mechanism of many o f  the sarcolemmal effects o f  higher 
concentrations ( >  IO/i M)  o f  palmitoyl carnitine eg. inhibition o f  N a ”*“-C a ^ +  exchange 
(Philipson & Nishimoto, 1982; Lamers et a l . ,  1984) and inhibition o f  excitatory ion 
currents (Inoue & Pappano, 1983; Meszaros et al., 1988). In the present studies the 
concentrations o f  P IP i  and palmitoyl carnitine used were the same (lOnM), and higher 
concentrations o f  palmitoyl carnitine than o f  P IP i  may be required in order to produce 
an increase in positive charge on the sarcolemmal surface, which may explain the lack 
o f  effect o f  palmitoyl carnitine on positive inotropic responses in the present 
experiments. In addition, both the lack o f  effect o f  palmitoyl carnitine on the positive 
inotropic response and the opposite effect o f  palmitoyl carnitine to that o f  P IP i in the 
coronary vasculature ie. coronary constriction rather than dilation may be due to other
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effects of palmitoyl carnitine on the positive inotropic response and the opposite 
effect of palmitoyl carnitine to that of PIPi in the coronary vasculature ie. coronary 
constriction rather than dilation may be due to other effects of palmitoyl carnitine 
counteracting the inhibition o f  calcium currents. For example, Wu & Corr (1992) 
using direct electrophysiological measurements within cardiac myocytes showed that 
palmitoyl carnitine decreased calcium currents but produced an increase in 
intracellular calcium secondary to an increase in intracellular sodium via a slowed 
inactivation o f  N a -1- inward current (Wu & Corr, 1994), and hence calcium entry 
through reversed Na +  -Ca2 +  exchange. This may also trigger calcium-induced 
calcium release from the sarcoplasmic reticulum (Leblanc & Hume, 1990), as the 
release channel has been shown to be situated close to the exchanger (Moore et al.,
1993), and therefore this may help explain the actions o f  palmitoyl carnitine to 
increase intracellular calcium. An increase in calcium release from the sarcoplasmic 
reticulum induced by palmitoyl carnitine has been shown in both skeletal (El-Hayek 
et al., 1993) and cardiac (Meszaros & Pappano, 1990) muscle. Studies showing 
palmitoyl carnitine to act as a calcium channel activator in smooth and cardiac 
muscle (Patmore et al., 1989; Spedding & M ir, 1987) were mostly indirect studies, 
and an increase in calcium may occur secondary to other cellular effects o f  palmitoyl 
carnitine. The effect of palmitoyl carnitine in vascular endothelial cells to inhibit 
agonist-induced release o f  nitric oxide (via the PLC / IP3 / DAG pathway) has been 
ascribed to supression o f  receptor mediated signal transduction following 
incorporation of the amphiphile into the sarcolemma (Inoue et al., 1994), since an 
inhibition o f  nitric oxide release mediated by several different agonists is produced 
eg. bradykinin-induced release (Inoue et a l.,  1994), ATP and carbachol mediated 
release (Dainty et a l.,  1990). In addition, palmitoyl carnitine has been shown to 
uncouple B-adrenoceptor mediated transduction pathways in the myocardium 
(Meszaros &  Levai, 1992; Abe et al., 1984). These effects reflect P IP i  mediated 
suppression o f  agonist-induced positive inotropic responses, and a similar mechanism 
may be responsible, although at the concentrations used in the present studies, no 
effect on positive inotropic responses was produced by palmitoyl carnitine itself.
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4. Effect o f palmitoyl carnitine and PIPi on ischaemia / reperfusion in the 
isolated rat heart.
As P IP i  had been shown to inhabit agonist-induced positive inotropic responses, 
produced by both a -  and B-adreinoceptor agonists and by PG F2 a , its effects on 
simulated ischaemia / reperfusion were also investigated, as this has been shown to 
induce both catecholam ine and prostaglandin release (Ceremuzynski et. a l., 1969; 
Berger et a l . ,  1976; Van der Vuisse & Reneman, 1985). Additionally, as P IP i  has 
been show n during the course otf these experiments to have characteristics in common 
with both calcium channel antagonists and potassium channel openers, P IP i  may be 
expected to exert protective effects in a model o f  global ischaemia / reperfusion.
Many classes o f  calcium channe 1 antagonist have been shown previously to exert 
protective effects from global ischaemic injury in isolated hearts (Watts et al., 1986), 
possibly via depression o f  card iac  contractility and conservation o f  high energy 
phosphates, which are depleted iin the ischaemic myocardium (Haworth et al., 1981), 
the result o f  which is impaired calcium homeostasis due to a run down of  membrane 
ion pumps in myocytes (Van deir Vusse & Reneman, 1985). An excessive increase in 
calcium entry through N a + - C a ^ +  exchange is thought to occur upon reperfusion, due 
to an increase in intracellular socdium following both a rundown o f  the sodium pump 
and stimulation o f  the Na +  - H +  exchanger as a consequence o f  ischaemia, and this is 
believed to contribute to the impairm ent of contractility upon reperfusion (Tani & 
Neely, 1989). Potassium chanmel openers eg. cromakalim have been shown to be 
protective, through both increasiing coronary flow upon reperfusion, reducing 
myocardial calcium levels and conservation o f  myocardial ATP levels (Weston & 
Edwards, 1992; Gross & Aucha.mpach, 1992; Grover, 1994). Specific calcium 'leak' 
channels, activated following A T P  depletion, are also implicated in ischaemia / 
reperfusion injury and cationic amphiphiles have been shown to have inhibitory effects 
on these channels (Clague et. al.., 1993; Clague & Langer, 1994). Therefore P IP i,  
another cationic amphiphile , m ay  confer protection via this mechanism.
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In these experiments, each period of  global ischaemia was limited to 20 minutes, so 
that recovery of  myocardial function occurred on reperfusion, as 40 minutes or more 
of ischaemia leads to irreversible myocardial cell injury due to calcium overload 
(Chien & Engler 1990). However there was a slight attenuation o f  basal contractility 
shown during each period o f  reperfusion, indicating that some damage had occurred. 
Neither P IP i  nor palmitoyl carnitine were able to significantly improve the recovery 
o f  developed tension on reperfusion, which has been shown to be restored by the 
administration o f  calcium antagonists (Watts et al., 1986; Chien & Engler 1990), 
suggesting that calcium entry through L-type calcium channels is involved in 
reversible injury to the myocardium. This may be related to the fact that calcium 
antagonists protect the heart via a decrease in basal myocardial contractility which 
conserves high energy phosphates (Watts et al., 1986; Haworth et al., 1981) and 
P IP i  does not affect basal contractility. However, potassium channel openers have 
also been shown to enhance recovery of contractility on reperfusion following global 
ischaemia (Grover et al., 1989; Gross & Auchampach, 1992), probably through 
preservation o f  cellular ATP levels, in the absence of  a reduction in myocardial 
contractility. The ischaemic contracture produced during the first 20 minutes of 
ischaemia, believed to be associated with loss of  tissue A TP (Haworth et al., 1981) 
was slightly reduced by the higher (lOOnM) concentration o f  PIP i used (Figures 37 
& 38). This ischaemic contracture occurs through an accumulation o f  intracellular 
calcium, the mechanism for which may involve increased calcium entry through L- 
type calcium channels, N a + -C a ^ “*“ exchange or calcium 'leak' channels or decreased 
calcium extrusion via sarcolemmal Ca2 +  -ATPase(Haworth et al., 1981; Tani & 
Neely, 1989; Clague et a l.,  1993). At higher concentrations, P IP i  may be able to 
inhibit calcium entry under conditions of ischaemia possibly by inhibition of  calcium 
entry through L-type calcium channels or inhibition o f  the calcium 'leak' channels, 
shown to be inhibited by other positively charged amphiphiles (see above). In 
addition, P IP i  was able to significantly inhibit the slowly developing coronary 
constriction which occurred following reperfusion (Figure 37 & 40). This could be 
due to the release o f  vasoconstrictor prostaglandins and catecholamines
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(Ceremuzynski et al., 1969; Berger et al., 1976), and PIPi might be inhibiting the 
release of these mediators or the coupling of these mediators to their respective 
second messenger systems, similarly to that suggested for the PIP i mediated 
inhibition o f  agonist-induced positive inotropic effects. The lack of  any significant 
effect of the parent compound palmitoyl carnitine on these responses indicates that it 
is a specific effect o f  the ester derivative. Further studies are required, however, to 
establish which mediators are involved in the coronary constrictor effect and also to 
investigate whether or not other coronary dilators eg. calcium antagonists, are able to 
produce the same effect in this preparation.
5. Effect o f PIPi in the isolated, stimulated left atrium of the rat.
These studies were performed to investigate whether PIP i can exert the same 
inhibitory effect in isolated cardiac muscle preparations, and to separate coronary 
vascular effects from the effects on cardiac muscle. Noradrenaline added 
cumulatively to the organ bath produced a cumulative increase in developed tension, 
due to B i -adrenoceptor stimulation and subsequent increase in calcium influx through 
calcium channels, following an increase in intracellular cAM P. in a similar way to 
that described in the perfused heart. An additional a-adrenoceptor mediated positive 
inotropic effect may also have contributed to the response (See section 3,
Discussion). P IP i  alone, up to ljuM had no effect on basal contractility in response 
to electrical stimulation, and did not affect the noradrenaline-induced positive 
inotropic response in this preparation, nor the twitch length in the presence of 
noradrenaline (Figures 41, 42 & 43). There are two possible explanations for the 
difference in the effect o f  P IP i  in the isolated stimulated left atrium, compared with 
the perfused heart preparation. Firstly, P IP i  present in the bathing solution is not 
able to gain access in sufficient concentration to exert an inhibitory effect in the 
stimulated atrium, and perfusion via the coronary vessels is a far more efficient 
mechanism for delivery o f  the compound to individual cardiac myocytes. Secondly,
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P IP i may be acting indirectly on cardiac muscle via the release o f  inhibitory 
substances from the coronary vasculature. In order to investigate these possibilities 
further, studies were performed in isolated myocytes, monitoring intracellular 
calcium levels by fluorimetric measurement.
6 . The effect of PIPi on calcium fluxes in isolated perfused rat myocytes by 
fluorimetric analysis.
In these experiments, a single myocyte stimulated at 1Hz, perfused at 2ml/min with 
Im M  C a ^ -1- physiological salt solution was found to produce transient increases in 
the 340/380 fura-2 signal ratio which synchronised with each electrical stimulation.
As explained in the results section, the 340/380 ratio is directly proportional to 
intracellular calcium concentration and therefore these increases represent 
intracellular calcium transients, brought about by depolarisation o f  the myocyte with 
each electrical stimulus, and subsequent calcium entry through L-type calcium 
channels. The addition of PIP i to the perfusion medium at a concentration of lOOnM 
produced no effect on the size of these basal calcium transients. This is in agreement 
with the results obtained in the isolated perfused rat heart in which P IP i  had no effect 
on basal contractility. However, P IP i did appear to increase the 'noise' of the 
measured calcium transients, producing less smooth increases in the 340/380 fura-2 
ratio signal in response to electrical stimulation (Figure 48a). This effect is less 
easily explained, but may involve the interaction o f  P IP i  with ion currents in the 
myocyte. This possibility requires further study. Noradrenaline was found to 
produce a slowly developing but sustained increase in calcium transients in individual 
myocytes (Figure 47a). A concentration-dependent response could not be produced 
to noradrenaline, due to the large variability in the responses to noradrenaline in 
different individual myocytes. This is not surprising as the entire population of 
ventricular myocytes was harvested from each heart, and therefore individual cells 
under investigation may have been from any region of  the left or right ventricle, and
are likely to vary in their adrenoceptor numbers and degree of response to electrical 
stimulation. Future studies could improve on this by harvesting cells from just one 
area o f  the heart eg. right ventricular cells. Despite variability between experiments, 
the average increase in the calcium transients was comparable to that obtained by 
other groups using similar concentrations of  isoprenaline (10nM-l/zM) ie. 150-200 % 
of control transients (Marsh, 1990; H a n c o x e ta l . ,  1994; Fenton e ta l . ,  1991). In 
addition to increasing the size of the calcium transients, noradrenaline also decreased 
the duration o f  the calcium transients (Figure 47b). This parallels the well 
established lusitropic action of B-adrenergic agonists, to shorten the time course of 
each contraction (Tsien, 1977). This effect is due to the ability of noradrenaline to 
enhance re-uptake of  calcium into the sarcoplasmic reticulum, by cAM P dependent 
protein kinase A-induced phosphorylation o f  phospholamban, which stimulates the 
SR C a ^ T -A T P ase  pump (Kranias, 1985; Davies et al., 1993), and also protein 
kinase A-mediated phosphorylation o f  troponin C which decreases the sensitivity of 
the myofilaments to calcium and increases the rate of  cross bridge detachments from 
actin (Puceat et a l., 1990; Strang et al., 1994). The complete inhibition o f  the 
noradrenaline-induced increase in the size o f  the calcium transients by atenolol 
(Figure 49) indicates that B receptor stimulation is responsible for these increases, via 
increased cA M P accumulation within the cell and a subsequent phosphorylation of L- 
type calcium channels by cAM P dependent protein kinase A. PIPi (lOOnM) also 
completely inhibited the noradrenaline-induced increase in calcium transients (Figure 
48a), probably via the same mechanism as in the isolated perfused heart (see above). 
This indicates that P IP i  is having a direct effect on the myocytes, and the inhibitory 
effect is not due to the release of mediator(s) from the coronary vasculature. 
Therefore, the lack o f  any effect o f  P IP i in the isolated stimulated left atrium is 
probably due to difficulties in the access o f  the molecule to individual myocytes.
The lack o f  effect o f  P IP i  on the noradrenaline-induced shortening of the duration of 
the calcium transient (Figure 48b) is indicative o f  the membrane surface effect of 
P IP i ,  and the inability to cross the sarcolemma to modulate intracellular processes 
eg. sarcoplasmic reticulum C a-  +  -ATPase. However, as indicated in the results
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section, P IP i  itself appeared to decrease the duration of the calcium transients which 
may imply a modulation of basal calcium within myocytes eg. a reduction in the 
action potential duration through an inhibition of currents through L-type calcium 
channels in a similar manner to that proposed in smooth muscle (Criddle et al.,
1994). This is an effect which cannot be observed in whole heart preparations.
The effects observed in response to caffeine in isolated myocytes ie. to increase the 
duration o f  the calcium transients, while having no effect on the amplitude (Figure 
50) may be explained by the fact that calcium release from the ryanodine sensitive 
calcium release channel o f  the sarcoplasmic reticulum, produced in response to 
caffeine (Rousseau & Meissner, 1989), occurs close to the sarcolemmal Na^"-Ca^ +  
exchanger, and calcium efflux via this exchanger may limit the peak of the Ca2 +  
transient in response to caffeine (Bassani et al., 1992). This may also explain the 
lack o f  effect o f  caffeine on myocardial contractility in the isolated perfused rat 
heart. The increase in duration of the calcium transient in the presence o f  caffeine 
may be due to an inhibition of reuptake o f  calcium, another effect produced by 
caffeine (Bers, 1985). The lack of  any effect of P IP i  on the action of caffeine is 
further evidence to suggest that PIP i does not affect calcium release from the 
sarcoplasmic reticulum.
As verapamil was able to block the calcium transients in response to electrical 
stimulation, this indicates that calcium entry is the initial trigger for depolarisation- 
induced calcium transients within myocytes.
Conclusions
These studies have investigated the actions o f  some novel palmitoyl carnitine 
derivatives, for example the isopropyl ester o f  palmitoyl carnitine (PIP i)  in coronary 
smooth muscle and cardiac muscle. The original aim was to investigate the 
mechanism o f  the coronary dilator response o f  these novel compounds. The 
structure-activity relationship studies have shown that the positive charge on the 
molecule is essential for coronary dilator activity, although the magnitude o f  the 
positive charge is not directly related to dilator potency. Studies in isolated rat hearts 
showing P IP i  to significantly reduce BAY K 8644 induced coronary constriction, 
whilst having no effect on constrictions produced in response to a low sodium 
perfusate or caffeine point to a mechanism o f  action via inhibition of calcium entry 
through L-type calcium channels in smooth muscle. However , experiments using 
TEA and a high potassium perfusate suggest P IP i  may interact with coronary smooth 
muscle potassium channels. This contradicts the findings o f  Criddle et al. (1994) in 
the mesenteric vascular bed. In the myocardium, the ability of PIP i to inhibit 
positive inotropic responses to noradrenaline, methoxamine and PG F2a  without 
affecting basal myocardial contractility or low sodium perfusate induced increases in 
contractility suggests an ability of P IP i to interact with signal transduction 
mechanisms.
As the positive charge on the molecule is essential for coronary dilator activity, and 
charged molecules do not readily cross lipid bilayers, it is likely that P IP i and related 
compounds are producing their effects on the sarcolemmal surface of the cell, to 
increase the transmembrane potential and hence reduce vascular and myocardial 
responsiveness. It is known that an increase in positive charge on the cell surface in 
the region o f  ion channels affects ion channel gating (Green & Andersen, 1991; 
Latorre et a l.,  1992). However, the interaction o f  P IP i with currents through 
specific ion channels, eg. calcium or potassium channels, in myocardial and coronary 
smooth muscle cells requires further study, using electrophysiological techniques.
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Future Work
Future work would focus on the study of P IP i in single cardic myocytes and smooth 
muscle cells, by fluorimetric measurement o f  intracellular calcium and 
electrophysiological techniques. In addition, the effects o f  PIPi on both the coronary 
vascular and myocardial effects o f  ischaemia / reperfusion could be investigated 
further.
1. Fluorimetric Analysis.
The fluorimetric analysis studies would continue from those studies so far carried out 
in isolated cardiac myocytes, as well as using cultured vascular smooth muscle, to 
investigate further the effects o f  P IP i  on agonist-induced changes in intracellular 
calcium. Various agents which increase intracellular calcium via increased influx or 
release from the sarcoplasmic reticulum would be used. These studies could be 
performed in the presence and absence o f  extracellular calcium to investigate the 
relative effects o f  P IP i  on calcium entry or sarcoplasmic reticulum calcium release.
2 . Electrophysiology.
The electrophysiological studies would focus on the interaction of PIPi with L-type 
calcium channels in isolated myocytes using whole cell patch clamp techniques. This 
would establish whether P IP i is able to modify the basal calcium current through L- 
type channels, as well as investigating the effect following activation with various 
agents eg. BAY K 8644, isoprenaline/noradrenaline, cholera toxin, forskolin and 
dibutyryl cyclic AM P. This will give a clearer picture as to whether P IP i is 
inhibiting L-type calcium channel currents via a direct G s protein interaction, via 
inhibition o f  the activation o f  adenylyl cyclase or inhibition o f  the activation of 
protein kinase A. The effects of methoxamine and PG F2 a  would also be
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investigated to establish whether they are able to modify L-type calcium currents 
directly, and this will help to elucidate the mechanism for the inhibition o f  the 
positive inotropic actions of  these agents by P IP i in whole heart preparations. The 
effect o f  PIP i on other currents, eg. T-type calcium channel currents, would also be 
investigated in myocytes.
The effect o f  PIP i on calcium currents in vascular smooth muscle cells would also be 
investigated to establish whether PIP i has a different mechanism o f  action in smooth 
muscle to that in cardiac muscle. The effect o f  P IP i  on other calcium channels in 
smooth muscle as well as L-type calcium channels, eg. R-type calcium channels, 
would be investigated. In addition, electrophysiological studies would be carried out 
to further investigate any interaction between P IP i  and the various K +  channels 
present in myocardial and vascular smooth muscle.
3. The effect of PIPi on ischaemia / reperfusion.
These studies would continue from those already carried out, ie. on 20 minutes 
ischaemia / reperfusion in the isolated rat heart. Firstly, to see whether higher 
concentrations o f  P IP i  can significantly inhibit the ischaemic contracture developed 
within the myocardium. Secondly, to establish the mechanism for the slowly 
developing coronary constriction produced on reperfusion, ie. whether the release of 
constrictor mediators is involved, in order to elucidate the mechanism for the PI Pi- 
mediated inhibition o f  constriction. Other experiments would investigate whether 
this inhibition can be mimicked by other vasodilators eg. calcium antagonists.
Additionally, the effect of PIP i on more prolonged ischaemia could be studied; and 
also any protective effects o f  PIPi against the development o f  arrhythmias following 
regional ischaemia / reperfusion.
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